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Executive summary 
dŚŝƐƌĞƉŽƌƚƵƉĚĂƚĞƐƚŚĞĞŶƚƌĞĨŽƌ,ĞĂůƚŚĐŽŶŽŵŝĐƐ ?ƚŝŵĞ-series of National Health Service (NHS) 
productivity growth. The full productivity series runs from 1998/99, but this report updates the 
series to account for growth between 2013/14 and 2014/15, as well as looking at 10 year growth 
trends since 2004/05. 
 
NHS productivity is measured by comparing growth in the outputs produced by the NHS to growth in 
the inputs used to produce them.  NHS outputs include the amount and quality of care provided to 
patients.  Inputs include the number of doctors, nurses and support staff providing care, the 
equipment and clinical supplies used, and the hospitals and other premises where care is provided. 
 
The measure of NHS output captures all the activities undertaken for all NHS patients wherever they 
are treated in England.  NHS output has increased between 2004/05 and 2014/15 primarily because 
ever more patients are receiving treatment.  Compared to 2004/05, hospitals are treating 4.6 million 
(27%) more patients, while the number of outpatient attendances has increased by 19%. 
 
The output measure also accounts for changes in quality.  On the upside, there have been year-on-
year improvements in hospital survival rates.  On the downside, waiting times have been getting 
longer since 2009/10, although they remain shorter than they were in 2004/05.  Taking account of 
the amount and quality of care, overall NHS output increased by 51% between 2004/05 and 
2014/15.  Output growth between 2013/14 and 2014/15 amounted to 2.49%. 
 
Increased NHS output has come about in response to pronounced increases in NHS expenditure.  
This has funded both higher wages and more staff and resources.  Wages rose by 19% between 
2004/05 and 2014/15, while there was a 10% increase in the number of NHS staff. There has been 
increased use of agency staff, but there have been periods of retrenchment, notably whenever the 
hospital sector has been struggling to reduce deficits. 
 
Between 2004/05 and 2014/15 the use of materials and capital increased respectively by 111% and 
105%.  Altogether NHS inputs have increased by 46% since 2004/05, with input growth between 
2013/14 and 2014/15 amounting to 1.94%. 
 
We calculate productivity growth by comparing output growth with input growth.  Over the last 
decade NHS productivity has increased by 13.63% in total.  Productivity growth has been especially 
strong since 2009/10, year-on-year growth averaging 1.37%.  Growth between 2013/14 and 
2014/15, as these latest figures show, amounted to 0.53%. 
 
This rate of NHS productivity growth since 2004/05 compares favourably with that achieved by the 
economy as a whole.  Annual NHS productivity growth kept pace with that of the economy up to the 
recession in 2008/09.  Since then NHS productivity growth has consistently outpaced that of the 
economy, which has stagnated. 
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Glossary of acronyms 
A&E Accident & Emergency 
AD Admitted 
ALB Arm's Length Body 
CCG Clinical Commissioning Group 
CDEL Capital Departmental Expenditure Limit 
CIPS Continuous Inpatient Spell 
CQC Care Quality Commission 
CSU Commissioning Support Unit 
DH Department of Health 
ESR Electronic Staff Record 
EQ5D EuroQol five dimensions standardized instrument for measuring 
generic health status 
FCE Finished Consultant Episode 
FTE Full-time Equivalent 
H&SC Act Health & Social Care Act 2012 
HES Hospital Episode Statistics 
HRG(4/4+) Healthcare Resource Group (version 4/4+) 
ISHP Independent Sector Health Care Provider 
MH Mental Health 
MSG Major Staff Group 
NAD Not admitted 
NHS National Health Service 
ONS Office for National Statistics 
PCA Prescription Cost Analysis 
PCT Primary Care Trust 
PROMs Patient Reported Outcome Measures 
PSSRU Personal & Social Services Research Unit 
QOF Quality and Outcomes Framework 
RC Reference Costs 
RDEL Revenue Departmental Expenditure Limit 
RDNA Regular Day and Night Attendance 
SHA Strategic Health Authority 
SUS Secondary Uses Service 
TDEL Total Departmental Expenditure Limit 
TFR Trust Financial Returns 
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1 Introduction 
dŚŝƐƌĞƉŽƌƚƵƉĚĂƚĞƐƚŚĞĞŶƚƌĞĨŽƌ,ĞĂůƚŚĐŽŶŽŵŝĐƐ ?ƚŝŵĞ-series of National Health Service (NHS) 
productivity growth. The full productivity series runs from 1998/99 (Bojke et al., 2016b), but this 
report updates the series to account for growth between 2013/14 and 2014/15, as well as looking at 
10 year growth trends dating from 2004/05.  
 
We follow national accounting conventions to measure the change in productivity over time by 
means of a chained index (Eurostat, 2001).  We concentrate on the calculation and comparison of 
output and inputs between 2013/14 and 2014/15.  dŚŝƐůĂƚĞƐƚ ‘ůŝŶŬ ?ŝƐƚŚĞŶĂƚƚĂĐŚĞĚƚŽƚŚĞĐŚĂŝŶĞĚ
index that reports productivity changes over the last decade. 
 
In calculating output growth, we construct a Laspeyres index aggregating different types of NHS 
ŽƵƚƉƵƚƵƐŝŶŐĂƐǁĞŝŐŚƚƐƚŚĞƉƌĞǀŝŽƵƐǇĞĂƌ ?ƐĐŽƐƚĨŽƌĞĂĐŚƐƉĞĐŝĨŝĐŽƵƚƉƵƚ ? We capture changes in 
quality by taking account of changes in survival following hospital treatment, waiting times, and 
improvements in blood pressure monitoring in primary care.  Improvements in these dimensions 
contribute to output growth. 
 
Growth in the volume of inputs is calculated primarily using expenditure data.  Current spending on 
ůĂďŽƵƌ ?ĐĂƉŝƚĂůĂŶĚŵĂƚĞƌŝĂůƌĞƐŽƵƌĐĞƐĂƌĞĚĞĨůĂƚĞĚƚŽƚŚĞƉƌĞǀŝŽƵƐǇĞĂƌ ?ƐĐŽƐƚƐŝŶŽƌĚer to facilitate a 
meaningful comparison of the volume of input use in the paired years.  For labour we also use 
information about the volume and costs of staff recorded in the NHS Electronic Staff Record (ESR).  
This permits two alternative measures of input growth  W one constructed entirely from accounts 
data (the indirect measure) and one which uses expenditure data for capital and materials and ESR 
data for labour (the mixed measure of input growth).  This allows us to assess how sensitive 
productivity growth is to how labour input is measured. 
 
The focus of the report is on the data used to calculate output and input growth between 2013/14 
and 2014/15.  Specific details are provided about any potential data collection and coding artefacts 
that may compromise a genuine like-for-like comparison across the two years. 
 
The structure of the report is as follows.  The output index is described in Section 2, and the 
elements of the input index are reported in Section 3. Section 4 reports the productivity growth 
figures. Summary and concluding remarks are provided in Section 5. 
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2 Output 
 Measuring output 2.1
Our NHS output index is designed to capture all activities provided to NHS patients, whether by NHS 
or private sector organisations.
1 
 Table 1 below summarises data sources used to measure activity, 
quality and costs, and also indicates specific measurement issues that have had to be tackled in 
constructing the output growth index for 2013/14  W 2014/15.  The data and these specific issues are 
detailed in the remainder of this section.  It should be noted that we have two alternative sources of 
volume of activity for outpatient output: the Hospital Episode Statistics (HES) outpatient dataset, 
and the Reference Costs database.  We compare the outpatient activity in these datasets. 
 
Table 1: Summary of output data sources 
Output type Activity source Cost source Quality Notes for 2013/14 and 
2014/15 data 
 Elective HES RC 30-day/in- hospital 
survival;  
health outcomes; 
waiting times 
Activity described by HRG4+ 
In-hospital survival is used for 
years 2013/14 and 2014/15   
Non-elective HES RC 30-day /in-hospital 
survival; health 
outcomes 
Activity described by HRG4+ 
In-hospital survival is used for 
years 2013/14 and 2014/15 
Outpatient HES (or RC)  RC Waiting times Waiting time comes from HES 
Two sources of activity data 
Mental health HES & RC RC 30-day/in-hospital 
survival;  
health outcomes; 
waiting times 
Activity described by HRG4+ 
In-hospital survival is used for 
years 2013/14 and 2014/15 
Community 
care 
RC RC N/A  
A&E RC RC N/A  
Other (1) RC RC N/A  
Primary care QResearch (up 
to 2008/09) 
General Lifestyle 
Survey 
(2008/09-09/10) 
GP patient 
survey (from 
2009/10) 
PSSRU Unit 
Costs of Health 
and Social Care 
QOF data Uplift survey responses by 
population growth; changes in 
QOF data 
Prescribing Prescription 
cost analysis 
system 
Prescription 
cost analysis 
system 
N/A  
Ophthalmic and 
dental services 
NHS Digital NHS Digital N/A  
Note: (1) Radiotherapy & High Cost Drugs, Diagnostic Tests, Hospital/patient Transport Scheme, Radiology, Rehabilitation, 
Renal Dialysis, Specialist Services 
                                                          
1
 NHS activity provided by non-NHS providers was included in the output growth series up to 2010/11. 
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 HES inpatient, day case, mental health  and outpatient data 2.2
HES is the source of data for both the amount of activity and for the measures of quality for elective 
and non-elective activity, including mental health care delivered in hospitals.
2
  HES comprises of 
almost 19.5m records for 2013/14 and 20.2m in 2014/15.  We convert HES records, defined as 
Finished Consultant Episodes (FCEs), into Continuous Inpatient Spells (CIPS) using the official 
algorithm for calculating CIPS published by NHS Digital (formerly the Health and Social Care 
Information Centre).
3
  We then count the number of CIPS in each Healthcare Resource Group (HRG), 
which form the basic means of describing different types of hospital output. 
 
The cost of each CIPS is calculated on the basis of the most expensive FCE within the CIPS, with costs 
for each HRG derived from the Reference Cost data (Bojke et al., 2013), our previous research 
suggesting that results are not sensitive to the alternatives of calculating the costs of CIPS on the 
basis of the first episode or the sum of all episodes (Daidone and Street, 2011).  Reference Costs are 
reported for each HRG according to their point of delivery, indicating whether the patient was 
treated as non-elective inpatient, elective inpatient or elective day case (Department of Health, 
2015). The non-elective Reference Costs are used to determine the cost of patients treated on a 
non-elective basis, while we use the elective inpatient Reference Costs to determine the cost of all 
elective patients, including those treated on a day case basis (Bojke et al., 2016a). This ensures that 
elective inpatient and daycase activity is assigned the same cost weight and, hence, is assumed to be 
of equivalent value, despite the latter being of lower cost. This equal weighting ensures that the 
output index is not biased downwards if delivery of treatment moves to lower cost forms or settings 
over time. Having assigned a cost to each CIPS, we then calculate the national average cost per CIPS 
in each HRG.   
 
There was a big overhaul of the HRG grouping system between 2013/14 and 2014/15. The number 
of HRGs increased from 2,289 in 2013/14 to 2,782 in 2014/15; however, only a third of HRGs are 
common between the two years. We observe 1,102 new HRGs in 2014/15 that were not existing in 
the previous year; further, 609 HRGs were discontinued and 51 HRGs changed their definition 
between the two years.  
 
Changes to the HRG system pose some difficulties in constructing the output index because costs 
might not be available for some activities.  In such cases we deflate current costs in order to impute 
prior values (Castelli et al., 2011). 
 
The vast majority of activity captured in HES is performed by hospital Trusts.  As shown in Table 2, 
97.5% of all activity was performed in Trusts in 2013/14 and 97.3% in 2014/15.  The proportion of 
activity performed by private providers is gradually increasing: in 2012/13 they provided 2.1% of all 
activity, increasing to 2.4% in 2013/14 and to 2.6% in 2014/15. 
 
Table 2: Organisational coverage of HES activity, FCEs 
Year NHS Trusts Private providers Other
4
 Total 
2012/13 18,649,728 406,078 13,754 19,069,560 
2013/14 19,061,786 470,454 1,873 19,534,113 
2014/15 19,639,539 537,998 3,501 20,181,038 
 
                                                          
2
 As in previous years, we exclude patients categorised to ,Z'ƐǁŚŝĐŚĂƌĞŶŽƚŝŶĐůƵĚĞĚŝŶƚŚĞƚĂƌŝĨĨ ? “ĞƌŽŽƐƚ,Z'Ɛ ? ) ? 
3
 http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID=1937&categoryID=1072. 
4
 Primary Care Trusts (2012/13 only) and organisations with the org_code starting with 8 or A. 
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2.2.1 Elective, day case and non-elective activity 
As can be seen from Table 3, elective and day case activity has increased by 50% over the full 
decade, from 6.4m to 9.7m CIPs, while non-elective activity has increased by 23%, from 6m to 7.4m 
CIPs.  While elective activity has grown steadily, growth in non-elective activity shows a more erratic 
pattern, as can be also observed in Figure 1.  Between 2013/14 and 2014/15 the number of elective 
CIPS increased by 314,587 (3.4%), while non-elective activity increased by 301,512 (4.2%). 
 
Table 3: Number of CIPS and average cost for electives and non-electives 
Year Elective and day case activity  Non-elective activity 
 # CIPS Average cost (£) # CIPS Average cost (£) 
2004/05 6,433,933 1,031  6,009,802 1,210 
2005/06 6,864,612 1,041  6,291,117 1,241 
2006/07 7,194,697 1,036  6,363,388 1,244 
2007/08 7,598,796 1,091  6,593,136 1,237 
2008/09 8,148,229 1,147  6,826,035 1,354 
2009/10 8,465,757 1,227  6,951,379 1,413 
2010/11 8,755,081 1,263  7,109,358 1,460 
2011/12 8,946,909 1,287  7,049,528 1,498 
2012/13 9,030,530 1,341 1,465* 7,327,228 1,532 
2013/14 9,336,918 1,373 1,501* 7,112,856 1,555 
2014/15 9,651,505  1,523* 7,414,368 1,569 
Note: * In previous years we calculated the cost for elective and day case activity as a weighted average between cost of 
elective and day case activity, but since 2012/13 we switched to using elective costs only. 
 
 
Figure 1: Changes in elective and day case and non-elective activity 
 
After cost-weighting this activity, we observe 3.70% growth in activity for electives and day cases 
and a small growth of 0.6% for non-elective activity between 2013/14 and 2014/15.  Combining 
both series, the total cost-weighted activity growth amounts to 1.94%. 
6,000,000
6,500,000
7,000,000
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9,000,000
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Elective and day case activity Non-elective activity
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2.2.2 Elective, day case and non-elective activity: quality adjustment 
Our measure of hospital output captures growth in both the volume of activity and improvements in 
quality.  The quality of hospital activity is measured by survival rate, estimated change in health 
outcomes following hospital treatment and mean life expectancy. Up to the financial year 2013/14, 
we used 30-day post discharge survival rate, but we have since switched to the in-hospital survival 
measure because ONS date of death data were not released to us.
5
  This part of the quality 
adjustment is designed to capture changes in the expected discounted sum of lifetime Quality 
Adjusted Life Years (QALYs) conditional on patients surviving treatment. 
 
Our quality adjustment also accounts for changes in inpatient waiting times.  Longer waiting times 
are considered to have adverse health consequences and formulated as a scaling factor multiplying 
the health effect (Castelli et al., 2007).  This adjustment applies only to elective and day case activity, 
and is measured by 80
th
 percentile waiting times.  Information on in-hospital survival rate and 
waiting times is obtained directly from HES; 30-day survival post-discharge was calculated from the 
mortality dataset provided by ONS; mean life expectancy is taken from life tables published annually 
by ONS.
6
  Table 4 and Figure 1 -3 present average values for each of these measures over time. 
 
Table 4: Quality adjustment for elective and day case and for non-elective activity 
Year  Elective and day case activity  Non-elective activity 
 30-day 
survival 
rate 
In-
hospital 
survival 
rate  
Mean life 
expectancy 
80
th
 percentile 
waiting times 
30-day 
survival rate 
In-
hospital 
survival 
rate 
Mean life 
expectancy 
2004/05 99.38%  23.7 104 95.16%  34.1 
2005/06 99.47%  23.7 95 95.49%  34.3 
2006/07 99.51%  23.6 89 95.65%  34.6 
2007/08 99.72%  23.5 74 95.79%  34.7 
2008/09 99.74%  23.2 60 95.85%  34.4 
2009/10 99.76%  23.4 65 96.07%  34.6 
2010/11 99.78%  23.4 76 96.05%  34.8 
2011/12 99.45%  23.2 85 96.62%  34.6 
2012/13 99.50% 98.76% 23.2 82
a
 96.45% 97.77% 34.1 
2013/14
a
 99.44%  99.93% 23.2 81 96.32%  97.27% 34.0 
2014/15 - 99.93% 22.9 79 - 97.18% 33.4 
a 
Previously reported figures showed the average across HRGs; from 2012/13 the figures show average across patients.  
 
For the majority of hospital treatments, patients are not asked about their health status before or 
after treatment.  However, since April 2009, all providers of NHS-funded care have been required to 
collect Patient Reported Outcome Measures (PROMs) for all patients undergoing unilateral hip and 
knee replacement, varicose vein surgery and groin hernia repair.  The PROMs survey includes the 
EQ-5D questionnaire, which allows responses to be scaled from perfect health (=1) to death (=0). 
                                                          
5
For the years 2012/13 and 2013/14 we have both the 30-days post discharge and in-hospital survival data, allowing us to 
assess the sensitivity of results to the choice of measure. First, the correlation between the two measures is high (0.99); 
second, total Laspeyres output growth of HES activity from 2012/13 to 2013/14 amounts to 1.73% if using in-hospital 
survival rates and 1.81% if using 30-day survival rates, a difference of 0.08%. 
6
 http://www.ons.gov.uk/ons/rel/lifetables/national-life-tables/index.html 
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Patients report their health status before and either three or six months after surgery.  Table 5 
reports the ratio of these before and after responses for those responding to both questionnaires for 
each condition since the questionnaire was first introduced.  We use changes in this ratio to assess 
the impact that treatments have on ƉĂƚŝĞŶƚƐ ? health status over time. 
 
Table 5: Ratio of pre to post health status, based on EQ-5D 
Year Groin hernia 
repair 
Hip 
replacement 
Knee 
replacement 
Varicose vein 
removal 
2009/10 0.82 0.32 0.37 0.84 
2010/11 0.80 0.36 0.41 0.82 
2011/12 0.80 0.40 0.40 0.71 
2012/13 0.76 0.36 0.37 0.80 
2013/14 0.84 0.37 0.39 0.80 
2014/15 0.82 0.37 0.44 0.85 
 
For treatments where no such information is available, we assume that the ratio is 0.8 for elective 
care and 0.4 for non-elective care. 
 
There is little variation in mean life expectancy for those treated in hospital over the entire period, 
as shown in Figure 2.  A slight negative trend can be observed in recent years: this is mostly likely 
due to increases in the average age of people admitted to hospital, rather than lower quality of care. 
 
 
Figure 2: Mean life expectancy 
 
Waiting times decreased in 2014/15 compared to 2013/14, as shown in Figure 3.  Despite this recent 
improvement, waiting times remain much higher than they were in 2008/09, when they were at an 
historic low. 
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Figure 3: 80th percentile waiting times 
 
We calculate the quality adjustment for each specific HRG, and separately for electives and non-
electives.  The quality adjustment is therefore also influenced by a shift of activity towards more 
complicated cases.  Once we take quality adjustment into account, the total Laspeyres output 
growth of HES activity from 2013/14 to 2014/15 decreases from 1.94% to 1.83%.  
 
2.2.3 Inpatient mental health 
tĞŝĚĞŶƚŝĨǇŵĞŶƚĂůŚĞĂůƚŚƉĂƚŝĞŶƚƐĂƐƚŚŽƐĞĨŽƌǁŚŝĐŚƚŚĞ,Z'ĨĂůůƐŝŶƚŽƚŚĞƐƵďĐŚĂƉƚĞƌ “t ?
(Treatment of Mental Health Patients by Non-Mental Health Service Providers).  As seen in Table 6 
and Figure 4, there has been year-on-year variation over the last decade in the number of patients 
with mental health problems treated in an elective/ day case setting and a non-elective setting, but 
numbers have decreased over the last three years. 
 
Table 6: CIPS and average cost for inpatient mental health patients 
Year Elective and day case activity Non-elective activity 
 # CIPS Average cost (£) # CIPS Average cost (£) 
2004/05 45,624 689 123,983 1,012 
2005/06 41,439 673 120,203 1,012 
2006/07 38,408 656 115,560 1,012 
2007/08 33,993 1,141 112,475 1,364 
2008/09 25,792 1,133 109,636 1,319 
2009/10 28,143 1,195 121,610 1,365 
2010/11 30,714 1,297 125,823 1,445 
2011/12 31,142 1,318 135,315 1,318 
2012/13 31,078 1,358 145,787 1,358 
2013/14 25,438 1,368 136,916 1,385 
2014/15 24,757 1,384 131,029 1,401 
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Figure 4: Number of CIPS for elective, day case and non-elective mental health patients over time 
 
After cost-weighting mental health activity, we observe a decline of -4.11% between 2013/14 and 
2014/15.
 
 
 
2.2.4 Inpatient mental health: quality adjustment 
As with other inpatient activity, we also account for changes in the quality of inpatient mental health 
care.  We use the same quality adjusters as for other forms of inpatient activity, namely 30-day / in-
hospital survival rates, mean life expectancy and 80
th
 percentile waiting times, these measures are 
reported in Table 7. 
 
Table 7: Quality adjustments for mental health activity 
Year  Elective and day case activity  Non-elective activity 
 30-day 
survival rate 
In-hospital 
survival 
rate 
Mean life 
expectancy 
80
th
 
percentile 
waiting times 
30-day 
survival 
rate 
In-
hospital 
survival 
rate 
Mean life 
expectancy 
2004/05 97.72%  30.1 40 96.96%  28.7 
2005/06 98.01%  30.0 265 97.22%  28.9 
2006/07 98.15%  30.6 257 97.38%  29 
2007/08 98.64%  29.9 28 97.65%  27.7 
2008/09 98.71%  29.0 42 97.56%  27.3 
2009/10 98.61%  29.4 28 97.68%  27.7 
2010/11 98.85%  30.2 37 97.63%  27.8 
2011/12 98.83%  31.1 37 97.78%  27.3 
2012/13 98.41% 99.91% 29.6 52
a
 97.61% 97.29% 26.9 
2013/14
a
 98.72%  98.95% 30.6 54 97.52% 97.87% 27.4 
2014/15  99.10% 31.3 51  98.25% 27.1 
a 
Previously reported figures showed the average across HRGs; from 2012/13 the figures show average across patients. 
0
20,000
40,000
60,000
80,000
100,000
120,000
140,000
160,000
180,000
200,000
Elective and day case activity Non-elective activity
Productivity of the English NHS: 2014/15 update  9 
In the same way as for other HES inpatient activity, we also calculate quality adjustment based on 
the performance in a specific HRG (separated for electives and non-electives).  Once we take quality 
adjustment into account, output growth from 2013/14 to 2014/15 changes from -4.11% to -4.42%. 
 
2.2.5 HES outpatient activity 
The volume of outpatient activity can be derived from both the HES Outpatients Dataset and RC 
data, but we always use RC to determine costs.  A like-for-like comparison between the two datasets 
is not wholly possible because the activity data are recorded somewhat differently in each.  
Specifically, this is because it is not possible to classify HES activity into consultant led and non-
consultant led activity, which is the common definitional split for non-procedural activity in RC.  For a 
successful match, one would need consultant codes in HES, which are considered sensitive and were 
not available to us.  The HES outpatient activity classification is a combination of treatment speciality 
and SUS HRG code. 
 
Further differences between HES and RC recorded activity is that HES covers activity conducted by 
organisation types other than Trusts and HES contains data on appointments which were attended 
and those which were not.  For the purpose of this analysis we only include attendances which were 
attended, with these representing approximately 80% of recorded data.  Of non-attended 
appointments there are roughly equal proportions of cancelations by patients, cancelations by 
providers, and patients who failed to attend without prior warning. 
 
In order to match consultant-led and non-consultant-led activity definitions from Reference Costs to 
those in HES, weighted averages are taken to produce averages specific only to currency codes (e.g. 
WF01A) and service codes.  These averages are matched to HES activity.  An initial round of 
matching was based on a complete match of Reference Cost service code and currency code 
combination with HES treatment speciality and SUS HRG code.  This led to over 90% of records being 
matched to an associated RC code. 
 
Table 8: Volume and average cost over time 
Year All providers (excl. ISHP and 
 ?KƚŚĞƌpƌŽǀŝĚĞƌƐ ? ? 
Trusts only 
 Volume Average cost (£) Volume Average cost (£) 
2011/12 88,926,968 114.00 87,589,260 114.30 
2012/13 90,850,009 116.98 90,126,813 117.19 
2013/14 96,690,559 117.18 96,689,126 117.18 
2014/15 101,382,540 118.26 101,382,540 118.26 
 
Table 8 shows the volume of attended activity and average cost of activity for all providers, 
excluding Independent Sector Healthcare Providers (ISHP) and other providers.  Only hospital Trusts 
were included in order to make the series consistent with the previously reported series constructed 
using Reference Cost data.  After cost weighting the activity, the Laspeyres growth index is 3.52%. 
 
2.2.6 HES outpatient activity: quality adjustment 
We allow for changes in the quality of outpatient activity by taking account of changes in waiting 
times, as summarised in Table 9 and Figure 5.  The 80
th
 percentile waiting time was 57 days in 
2013/14, rising to 61 days in 2014/15.  Accounting for this has virtually no impact on the growth 
index which drops to 3.51%. 
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Table 9: Outpatient mean and 80
th
 percentile waiting times (days) 
Year DH HES HES 
 Mean 80
th
 Percentile 
2004/05 52   
2005/06 46   
2006/07 41   
2007/08 24 37  
2008/09 22 34  
2009/10 24 36  
2010/11  37  
2011/12  37  
2012/13  38 55 
2013/14  40 57 
2014/15  42 61 
 
 
Figure 5: Trends in outpatient waiting times 
 
 Reference cost data 2.3
Reference Cost (RC) returns are used to capture activity performed in most health care settings 
other than hospitals, outpatient departments and primary care.  In particular, RC data cover activity 
conducted in accident and emergency (A&E) departments, mental health and community care 
settings, and diagnostic facilities.  Activities are reported in various ways: attendances, bed days, 
contacts and number of tests. 
 
In 2012/13 and 2013/14, the RC returns only covered activity undertaken by hospital Trusts, but in 
2014/15 RC returns were also submitted for contracted-out activity, that is activity delivered by 
independent sector (non-NHS) providers.  This activity is, however, not included in this report 
because only a single yeaƌ ?Ɛǁorth of data is available. 
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RC returns also provide information on unit costs for all recorded activities (and about the costs of 
activity performed in hospitals and outpatient departments, as previously mentioned). 
 
There are two major issues that need to be considered when using the Reference Costs data for our 
purposes: 
 
1. The accuracy of the reported data 
2. The activity coverage 
 
2.3.1 General RC data validation checks 
Since 2011/12, the Department of Health has required mandatory and non-mandatory validations of 
the Reference Cost data reported by NHS Trusts (Department of Health, 2012).  These have reduced 
the year-on-year volatility in the information contained in the RC returns.  DH checks of the quality 
of Reference Cost returns are of the following nature: 
 
x Mandatory validations included checks that all data (both activity and cost) are reported, 
unit costs are reported as positive integers to two decimal places, no fields are missing, etc. 
 
x Non-mandatory validations include checking whether unit costs below £5 or over £50,000 
are accurate and whether single professional outpatient attendance unit costs were less 
than multi-professional unit costs.  
 
x &ŝŶĂůůǇ ?ĐŚĞĐŬƐŽŶ ‘ǇĞĂƌ-on-ǇĞĂƌĐŚĂŶŐĞƐ ?ĂƌĞĐĂƌƌŝĞĚŽƵƚ ?/ŶƉĂƌƚŝĐƵůĂƌ ?ĂŶǇĐŚĂŶŐĞŝŶƚŽƚĂů
cost or activity greater than 25% is flagged and double-checked.  The check is carried out by 
department code and HRG sub-chapter for acute services, or service code for non-acute 
services (only for outpatient attendances, outpatient procedures and emergency medicine). 
 
Over and above these checks, we have implemented our own validation process (Bojke et al., 2014).  
This focuses on identifying large increases/decreases in either volume or unit costs of activity for all 
non-acute services.  In particular, we check 1) whether volumes of activity have registered either an 
increase or decrease of more than 500,000 units or 2) whether the value of activity has registered an 
increase or decrease of more than £25 million. 
 
In the event that large scale changes are detected, we look at each activity in isolation to determine 
the most appropriate solution.  These may be: to leave as is, replace an unexpected high cost value 
with the minimum cost across the two years, or omit the category from the output index.  Our 
validation checks performed with the RC 2014/15 data show only one incongruity for 4 Renal Dialysis 
HRGs. See Table 10 for details. 
 
We believe that a coding error occurred for HRGs LD05B and LD06A, as the figures for both Volume 
of activity and Number of Data submissions (i.e. submissions by Trusts) in 2013/14 and 2014/15 
appear to be switched around.  In addition, the figures for Volume of activity and Number of Data 
submission for HRG LD04A in 2014/15 are very similar to those for HRG LD05A in 2013/14, as 
reported in Table 10. 
 
After correcting these apparent mistakes, we have decided to keep in our measure of output growth 
the HRGs LD05A, LD05B and LD06A for the financial year 2013/14 and the HRGs LD04A (which we 
have mapped with HRG LD05A for 2013/14), LD05B and LD06A for the financial year 2014/15.  We 
have dropped only one HRG in each financial year: LD04A in 2013/14 and LD05A in 2014/15.  The 
total volume of activity that has been excluded is 20,269 for HRG LD04A in 2013/14 and 83 for HRG 
LD05A in 2014/15. See Table 11 for mapping of HRGs.  
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Table 10: Coding issues for renal dialysis HRGs 
Year HRG Description 
Volume 
of 
activity 
Average 
cost 
(£) 
No Data 
submissions 
2013/14 
LD04A 
Hospital haemodialysis or filtration, with 
access via arteriovenous fistula or graft, 
with blood-borne virus, 19 years and 
over 
20,269 176 47 
LD05A 
Satellite haemodialysis or filtration, with 
access via haemodialysis catheter, 19 
years and over 
416,706 133 42 
LD05B 
Satellite haemodialysis or filtration, with 
access via haemodialysis catheter, 18 
years and under 
275 115 6 
LD06A 
Satellite haemodialysis or filtration, with 
access via arteriovenous fistula or graft, 
19 years and over 
1,092,718 153 42 
2014/15 
LD04A 
Hospital haemodialysis or filtration, with 
access via arteriovenous fistula or graft, 
with blood-borne virus, 19 years and 
over 
416,863 121 42 
LD05A 
Satellite haemodialysis or filtration, with 
access via haemodialysis catheter, 19 
years and over 
83 150 4 
LD05B 
Satellite haemodialysis or filtration, with 
access via haemodialysis catheter, 18 
years and under 
1,115,392 145 42 
LD06A 
Satellite haemodialysis or filtration, with 
access via arteriovenous fistula or graft, 
19 years and over 
345 135 7 
 
Table 11: Mapping of renal dialysis HRGs  
HRG  ? 2013/14  HRG-2014/15 
LD05A Î LD04A 
LD06A Î LD05B 
LD05B Î LD06A 
 
Table 12 summarises the RC data according to broad service settings over the past three years.  This 
shows that the number of categories is quite stable between 2013/14 and 2014/15 across the 
different settings, the exception being Radiology where the number of categories has almost 
doubled from 136 to 258 (although there were 5,047 in the 2012/13 collection). 
 
Despite changes in how activities are described, we are able to accommodate these in the 
measurement of output growth using RC data (Castelli et al., 2011).  This is because, although 
category descriptions differ, the old and new categories are generally capturing the same types of 
activity.
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Table 12: Reference cost settings 
Setting 2012/13 2013/14 2014/15 
 Nr 
Cat. 
Activity Cost (£) Nr 
Cat. 
Activity Cost (£) Nr 
Cat. 
Activity Cost (£) 
A&E and Ambulance Services 89 34,952,786 3,692,014,018 90 35,051,392 3,923,106,579 89 36,551,479 4,201,423,614 
Chemo/Radiotherapy & High Cost Drugs 317 6,754,603 2,652,051,626 323 6,988,301 2,915,174,231 344 7,567,487 3,351,048,218 
Community Care 149 79,709,044 4,139,765,181 174 85,975,592 4,864,684,367 180 85,733,534 5,052,768,659 
Diagnostic Tests 64 342,280,609 941,490,357 72 368,505,992 964,981,062 82 363,656,649 994,023,634 
Community Mental Health 117 260,266,214 6,311,927,307 124 259,659,214 6,410,525,825 129 262,460,243 6,489,460,422 
Outpatient 6,979 77,222,725 8,546,218,360 8,055 81,699,802 9,275,173,143 9,465 83,856,229 9,815,241,661 
Radiology 5,047 9,381,616 859,058,674 136 9,709,456 904,796,391 258 9,866,952 944,288,512 
Rehabilitation 119 2,715,650 817,792,033 113 3,002,512 893,588,640 121 3,008,889 954,413,054 
Renal Dialysis 40 4,135,914 528,076,698 40 4,079,238 533,459,915 39 4,070,447 533,927,599 
Specialist Services 86 4,359,263 2,927,444,066 145 4,699,893 3,030,502,560 145 4,967,499 3,252,277,420 
Other 3,099 4,763,955 354,760,843 937 3,927,412 309,107,379 1,119 3,407,664 287,913,867 
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2.3.2 RC outpatient activity 
Outpatient activity as measured in the RC database has tended to be classified into three major 
groups: consultant led activity; non-consultant led activity; and procedures.  Consultant and non-
consultant led activity represent broadly the same set of outpatient specific HRG-style codes 
(currency codes beginning with WF) and outpatient procedure codes represent procedure related 
HRGs which may appear in other hospital settings (for example in 2013/14 Reference costs, HRG 
AA21G [minor intracranial procedures] occurred 1,648 times as a hospital day case and 3,662 times 
as an outpatient procedure).  On average, consultant led activity for Trusts represents over 71% of 
overall outpatient cost-weighted activity.  Outpatient procedures have increased considerably in 
volume: representing just 3% of overall outpatient activity in 2007/08 and nearly 13% in 2014/15. 
 
Table 13: Outpatient activity and cost 
Year Outpatient 
 All providers Trusts only 
 Volume of activity Average cost 
(£) 
Volume of activity Average cost 
(£) 
2007/08 69,679,600 94 61,508,362 98 
2008/09 74,421,017 98 65,804,814 103 
2009/10 80,093,906 101 71,115,142 105 
2010/11 81,301,615 105 73,621,984 107 
2011/12 - - 75,826,947 108 
2012/13 - - 77,222,725 111 
2013/14 - - 81,699,802 114 
2014/15 - - 83,856,229 117 
 
The Laspeyres output growth measure for outpatient activity as captured by the Reference Costs 
data was 3.71% from 2013/14 to 2014/15, which compares to 3.52% when using the HES 
outpatients data. 
 
The difference between HES and RC measures of growth is very small, with RC reporting 0.19% 
higher growth.  Although both datasets have some quality issues, our preferred method uses HES, as 
it is a patient level dataset as opposed to the more aggregated RC.  This allows us to perform more 
thorough quality checks and better assure a like-for-like comparison over time. 
 
2.3.3 A&E and ambulance services 
Table 14 reports summary statistics for A&E services provided in Emergency Departments and Other 
A&E services according to whether patients were subsequently admitted to hospital (AD) or not 
admitted (NAD).  
 
Emergency departments offer a consultant-led 24 hour service with full resuscitation facilities and 
designated accommodation for the reception of A&E patients.
7
  Between 2013/14 and 2014/15 
there was an increase (of almost 2%) in the total number of emergency department attendances, 
but there was a 4% reduction in the number of people being admitted to hospital. 
                                                          
7
http://content.digital.nhs.uk/media/19424/AE-DD-Final-Doc/pdf/DD-AE-V7.pdf 
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dŚĞĐĂƚĞŐŽƌǇ ‘KƚŚĞƌ ?ƐĞƌǀŝĐĞƐ ?ĐĂƉƚƵƌĞƐĂĐƚŝǀŝƚŝĞƐĐĂƌƌŝĞĚŽƵƚŝŶĂŶǇŽĨƚŚĞĨŽůůŽǁŝŶŐ
ĚĞƉĂƌƚŵĞŶƚƐ P ‘ŽŶƐƵůƚĂŶƚůĞĚŵŽŶŽƐƉĞĐŝĂůƚǇĂĐĐŝĚĞŶƚĂŶĚĞŵĞƌŐĞŶĐǇƐĞƌǀŝĐĞƐ ?Ğ ?Ő ?ŽƉŚƚŚĂlmology, 
ĚĞŶƚĂů )ǁŝƚŚĚĞƐŝŐŶĂƚĞĚĂĐĐŽŵŵŽĚĂƚŝŽŶĨŽƌƚŚĞƌĞĐĞƉƚŝŽŶŽĨƉĂƚŝĞŶƚƐ ? ? ‘KƚŚĞƌƚǇƉĞŽĨ ? ?ŵŝŶŽƌ
injury activity with designated accommodation for the reception of accident and emergency 
ƉĂƚŝĞŶƚƐ ?ĂŶĚ ‘E,^tĂůŬ-in-ĞŶƚƌĞƐ ? ? ‘KƚŚĞƌ ?ƐĞƌǀŝĐĞƐ ?ŝŶĐreased overall by 6.9% between 
2013/14 and 2014/15, but there was a 9.7% reduction in the number of these subsequently being 
admitted to hospital.  Overall, the total volume of A&E activity increased by 3.1% between 2013/14 
and 2014/15. 
 
Table 14: A&E activity and average cost 
Year Emergency departments Other A&E services 
 AD NAD AD NAD 
 Volume of 
activity 
Average 
cost 
(£) 
Volume of 
activity 
Average 
cost 
(£) 
Volume of 
activity 
Average 
cost 
(£) 
Volume of 
activity 
Average 
cost 
(£) 
2006/07 3,464,869 107 10,327,147 83 281,135 50 3,900,718 36 
2007/08 3,326,719 121 9,058,765 89 531,498 70 3,769,765 43 
2008/09 3,566,642 118 9,708,958 99 1,000,986 49 4,184,796 49 
2009/10 4,047,176 134 10,075,701 103 1,090,650 49 3,628,469 50 
2010/11 4,004,868 141 9,881,747 108 1,145,125 62 3,800,261 55 
2011/12 4,040,760 157 10,405,762 108 616,812 83 3,253,452 52 
2012/13 4,345,100 160 10,292,933 115 362,656 90 3,426,231 59 
2013/14 4,218,480 177 10,189,225 127 494,549 80 3,639,355 59 
2014/15 4,050,701 206 10,636,666 133 446,779 65 3,972,875 61 
Legend: AD  W leading to admitted patient care; NAD  W Not leading to admitted patient care 
 
 
Figure 6: trend of A&E activity across settings 
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Ambulance services are reported in Table 15 for the four years since this activity was first recorded 
in the Reference Cost database.  Activity is measured in terms of calls received for the category 
 ‘ĂůůƐ ? ?ƉĂƚŝĞŶƚƐĨŽƌƚŚĞĐĂƚĞŐŽƌǇ ‘,ĞĂƌĂŶĚƚƌĞĂƚŽƌƌĞĨĞƌ ? ?ŝŶĐŝĚĞŶƚƐĨŽƌƚŚĞĐĂƚĞŐŽƌŝĞƐ ‘^ĞĞĂŶĚƚƌĞĂƚ
ŽƌƌĞĨĞƌ ?ĂŶĚĐĂƚĞŐŽƌŝĞƐ ‘^ĞĞĂŶĚƚƌĞĂƚĂŶĚĐŽŶǀĞǇ ? ? Overall activity by ambulance services increased 
ďĞƚǁĞĞŶ ? ? ? ? ? ? ?ĂŶĚ ? ? ? ? ? ? ? ?ǁŝƚŚƚŚĞĐĂƚĞŐŽƌǇ ‘,ĞĂƌ ?ĂůŽŶĞŝŶĐ ĞĂƐŝŶŐďǇ ? ? ? ?A? ?and the 
ĐĂƚĞŐŽƌǇ ‘^ĞĞĂŶĚƚƌĞĂƚĂŶĚĐŽŶǀĞǇ ?ŝŶĐƌĞĂƐing by just 0.8%. 
 
Table 15: Ambulance services 
Year Ambulance services 
 Calls Hear and treat or 
refer 
See and treat or 
refer 
See and treat and 
convey 
 Volume 
of activity 
Average 
cost 
(£) 
Volume 
of 
activity 
Average 
cost 
(£) 
Volume 
of activity 
Average 
cost 
(£) 
Volume 
of activity 
Average 
cost 
(£) 
2011/12 8,530,563 8 338,022 44 1,862,892 173 4,895,376 230 
2012/13 9,120,422 7 423,821 47 1,997,327 174 4,984,296 230 
2013/14 8,926,215 7 400,005 44 2,113,757 180 5,069,806 231 
2014/15 9,491,159 7 575,168 35 2,270,229 180 5,107,902 233 
 
dŚĞ>ĂƐƉĞǇƌĞƐŽƵƚƉƵƚŐƌŽǁƚŚŵĞĂƐƵƌĞĨŽƌƚŚĞƐĞƚƚŝŶŐ ? ?ƐĞƌǀŝĐĞƐ ? ?ǁŚŝĐŚŝŶĐůƵĚĞƐĂŵďƵůĂŶĐĞ
services, increased by 4.17% between 2013/14 and 2014/15. 
 
2.3.4 Chemotherapy, Radiotherapy & High Cost Drugs 
The categories used to describe Chemotherapy, Radiotherapy, and High Cost Drugs have been 
subject to substantial revision over time, making it difficult to infer much from the simple counts of 
activity reported below in Table 16 and Figure 7.  Between 2013/14 and 2014/15, however, 
categorisation has been fairly stable, with only High Cost Drugs experiencing an increase in the total 
number of categories (20 new groups were introduced in 2014/15).  Radiotherapy had one new 
category added in 2014/15 and one dropped, whilst Chemotherapy had no categorisation changes.  
The total volume of Chemotherapy activity increased by 7.5%, that of Radiotherapy by 3.4% and that 
of High Cost Drugs by 17.9% (some of this increase might be due to new categories capturing 
previously unrecorded activity, though this cannot be determined).  
 
The Laspeyres output growth measure for Chemotherapy, Radiotherapy & High Cost Drugs was 
16.34% between 2013/14 and 2014/15.  
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Table 16: Chemotherapy, Radiotherapy, High Cost Drugs 
Year Chemotherapy Radiotherapy High Cost Drugs 
 Volume of 
activity 
Average 
cost  
(£) 
Volume of 
activity 
Average 
cost  
(£) 
Volume of 
activity 
Average 
cost  
(£) 
2004/05 777,312 363 1,622,278 113 - - 
2005/06 763,806 432 1,634,156 126 - - 
2006/07 1,642,444 280 1,743,490 123 26,277,491 17 
2007/08 846,425 406 1,613,135 559 1,332,996 305 
2008/09 1,428,561 448 1,710,525 157 1,322,354 473 
2009/10 1,414,872 505 1,835,695 163 2,412,988 384 
2010/11 1,515,845 515 2,001,798 161 1,288,460 818 
2011/12 1,769,727 505 2,492,431 137 1,372,131 902 
2012/13 2,525,935 387 2,717,024 127 1,511,644 878 
2013/14 2,540,353 431 2,760,237 134 1,687,711 859 
2014/15 2,729,954 449 2,855,371 135 1,982,162 877 
Note: In 2006/07, High Cost Drugs were recorded as number of procurements, after which recording was by number of 
patients. 
 
 
In 2006/07, High Cost Drugs were categorised and costed differently to subsequent years, hence 
this data point has not been included in the Figure. 
Figure 7: Laspeyres output growth for Chemotherapy, Radiotherapy and High Cost Drugs over time 
 
2.3.5 Community care 
Table 17 reports total volumes of Community Care activity from 2004/05 to 2014/15.  While the 
provision of community care has decreased since 2009/10, this is primarily due to Primary Care 
Trusts (and Personal Medical Services pilots) no longer reporting this activity after 2010/11.  
Community care activity decreased slightly in 2014/15 (0.3%). 
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Table 17: Community care activity 
Year Community care 
 Volume of activity (a) Average cost (£) 
2004/05 75,673,792 39 
2005/06 85,092,838 38 
2006/07 83,895,139 40 
2007/08 85,470,688 42 
2008/09 88,513,663 45 
2009/10 92,412,727 46 
2010/11 90,724,524 47 
2011/12 78,315,576 50 
2012/13 79,709,044 52 
2013/14 85,975,592 57 
2014/15 85,733,534 59 
Note: In 2011/12, PCTs and PMS ceased to report activity about community care. Total volume of 
activity from 2011/12 is, therefore, not comparable with previous years. 
 
 
Figure 8: Trend in community care activity 
 
In 2013/14 three new types of activities were introduced: Community Intermediate care activity, 
Wheelchair services and Other Therapists. As a consequence for the calculation of the Output 
growth index between 2012/13 and 2013/14, we omitted the three new types of activity. Further, 
Community Intermediate care activity included activity previously recorded as Hospital at Home and 
Early Discharge Scheme and Community Rehabilitation teams, so the latter were also dropped from 
the financial year 2012/13. In 2014/15 all the above activities have been recorded in a consistent 
fashion to the data in 2013/14, so it has now been possible to include this information in our 
measure of NHS output growth.  
 
The Laspeyres output growth index for Community Care activity between 2013/14 and 2014/15 is 
0.22%. 
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2.3.6 Diagnostic tests, pathology and radiology 
Table 18: Directly accessed diagnostic and pathology services and radiology 
Year Directly accessed diagnostic 
services 
Directly accessed pathology 
services 
Radiology 
 Volume of 
activity 
Average cost 
(£) 
Volume of 
activity 
Average cost 
(£) 
Volume of 
activity 
Average cost 
(£) 
2004/05 369,988 44 180,676,234 3 5,152,720 31 
2005/06 465,622 44 221,966,384 2 5,784,605 33 
2006/07 735,569 137 236,269,050 2 23,918,500 59 
2007/08 776,368 41 257,249,379 2 7,614,437 103 
2008/09 804,607 46 278,917,852 2 7,852,498 102 
2009/10 1,063,744 43 300,010,031 2 8,347,404 104 
2010/11 1,458,025 39 320,418,662 2 8,491,834 97 
2011/12 5,640,762 34 333,108,317 2 8,758,136 93 
2012/13 6,339,016 30 335,941,593 2 9,381,616 92 
2013/14 6,553,727 31 361,952,265 2 9,709,456 93 
2014/15 7,128,172 32 356,528,477 2 9,440,280 88 
Note: In 2004/05 and 2005/06, radiology was recorded as number of tests; in 2006/7 it comprised number of tests and 
interventions; from 2007/08 it was number of patients. 
 
In 2013/14, the number of distinct categories in Radiology fell from 5,047 categories to just 136.  
Further inspection revealed this to be a result of a decrease in the granulation of measurement.  In 
2014/15, a further minor change was introduced for Radiology activity in that the coding for all its 
activity was changed from RA*** codes to RD*** codes, but with the same description of activity 
recorded.  However, a substantial re-categorisation occurred for Nuclear Medicine, which in 2013/14 
comprised only of 7 categories, but now has increased its granularity, bringing the total number of 
categories to 137. 
 
The total volume of Directly Accessed Diagnostics services and Radiology increased by 8.8% and 
1.6%, respectively between 2013/14 and 2014/15.  Directly Accessed Pathology services decreased 
by 1.55 over the same time period.  The Laspeyres output growth for each broad type of test was 
7.62%, -2.39% and 2.62% respectively, leading to an overall growth for these combined activities 
of 1.13%. 
 
2.3.7 Community mental health 
Table 19 summarises overall counts of Community Mental Health activity since 2004/05.  Activity in 
this setting underwent a major revision in 2011/12 with the creation of mental health clusters but 
has since appeared to settle into a consistent measurement scheme.  
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Table 20 provides a more detailed breakdown of Community Mental Health activity since the 
clusters were first employed. 
 
Table 19: Community mental health 
Year Community mental health 
 Volume of 
activity 
Volume of 
activity (a) 
Average 
cost (£) 
2004/05 16,389,891  164 
2005/06 17,738,894  170 
2006/07 19,259,205  167 
2007/08 21,751,043  153 
2008/09 22,674,811  157 
2009/10 23,440,616  161 
2010/11 24,341,950  159 
2011/12  224,329,080 28 
2012/13  260,266,214 24 
2013/14  259,659,214 25 
2014/15  262,460,243 25 
Note: Due to the reclassification of activity in Community Mental Health, data from 2011/12 are not directly comparable 
with data reported in previous years. Hence, Community mental health activity was excluded from the calculations of both 
the Community Mental Health and the overall NHS output growth indices for the pair of years 2010/11 to 2011/12. 
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Table 20: Care clusters and other mental health activity 
Community mental health 2011/12 2012/13 2013/14 2014/15 
 Volume of 
activity 
Average 
cost (£) 
Volume of 
activity 
Average 
cost (£) 
Volume of 
activity 
Average 
cost (£) 
Volume of 
activity 
Average 
cost (£) 
Care Clusters         
Mental Health  W Care Clusters  W Admitted Patient Care 5,900,173 334 5,548,751 348 8,822,616 222 5,389,210 365 
Mental Health - Care Clusters - Non-Admitted Patient Care 208,657,970 11 244,072,900 9 239,045,781 9 245,102,673 9 
Mental Health  W Care Clusters  W Initial Assessment 418,356 251 816,112 264 746,982 281 755,151 293 
        dŽƚĂůǀŽůƵŵĞ ?DĞŶƚĂů,ĞĂůƚŚĂƌĞůƵƐƚĞƌƐ ? 214,976,499 20 250,437,763 17 248,615,379 17 251,247,034 17 
        
Other Mental Health        
Secure Units 1,537,140 523 1,526,840 532 1,543,448 516 1,565,824 522 
Day Care Facilities: Regular Attendances 28,782 294 34,969 294 41,555 305 30,482 318 
Outpatient Attendances
*
 1,343,458 156 615,632 217 721,849 182 1,019,875 184 
Community Contacts 3,309,410 135 2,970,529 161 2,642,912 188 3,285,139 173 
Specialist Teams 3,133,791 140 4,680,481 120 6,094,071 117 5,311,889 118 
        
Total volume Other Mental Health 9,352,581 204 9,828,451 203 11,043,835 195 11,213,209 197 
Total volume of Community MH activity 224,329,080 28 260,266,214 24 259,659,214 25 262,460,243 25 
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In terms of raw activity, Community Mental Health increased by 1.1% from 2013/14 to 2014/15, but 
there was a shift toward more costly activities with cost-weighted output growth amounting to 
3.03%. 
 
2.3.8 Rehabilitation and renal dialysis 
Table 21: Rehabilitation and renal dialysis 
Year Rehabilitation Renal dialysis 
 Volume of activity Average cost  
(£) 
Volume of activity Average cost 
(£) 
2004/05 4,095,087 178 8,232,432 52 
2005/06 4,509,489 185 6,819,136 64 
2006/07 3,028,598 241 4,200,298 104 
2007/08 2,732,048 259 3,980,793 114 
2008/09 3,277,757 265 4,091,245 120 
2009/10 3,277,430 279 4,050,658 129 
2010/11 3,314,085 285 4,088,817 129 
2011/12 2,897,721 278 4,166,150 129 
2012/13 2,715,650 301 4,135,914 128 
2013/14 3,002,512 298 4,069,460 131 
2014/15 3,008,889 317 4,070,447 131 
 
The volume of rehabilitation and renal dialysis activity over time is reported in Table 21. The total 
volume of Rehabilitation services increased by 0.2% between 2013/14 and 2014/15, and the total 
volume of Renal Dialysis remained virtually unchanged.  The Laspeyres output growth for 
Rehabilitation and Renal Dialysis services were, respectively, 2.35% and 2.43% between 2013/14 
and 2014/15. 
 
2.3.9 Specialist services 
The volume and cost of various types of specialist services are reported in Table 22. 
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Table 22: Specialist services  
Year Adult critical care 
Specialist palliative 
care 
Cystic fibrosis 
Cancer multi-
disciplinary team 
meetings 
 Volume of 
activity 
Average 
cost (£) 
Volume of 
activity 
Average 
cost (£) 
Volume of 
activity 
Average 
cost (£) 
Volume 
of activity 
Average 
cost (£) 
2004/05 2,184,333 828 - - 16,317 1,919 - - 
2005/06 2,197,135 895 - - 13,704 2,316 - - 
2006/07 2,468,777 840 93,880 269 13,944 2,290 - - 
2007/08 2,165,060 931 208,410 219 15,383 2,349 - - 
2008/09 2,354,447 967 262,305 216 20,756 2,116 - - 
2009/10 2,439,661 1,003 359,121 192 20,323 2,468 - - 
2010/11 2,470,065 1,011 512,972 162 19,942 2,631 - - 
2011/12 2,570,571 998 550,417 166 9,852 8,476 837,418 114 
2012/13 2,669,343 984 600,848 169 9,735 8,709 1,079,297 106 
2013/14 2,708,897 992 701,439 158 9,990 10,213 1,279,567 101 
2014/15 2,746,664 1,044 775,488 157 10,767 9,810 1,434,580 111 
The total volume of Adult Critical Care services increased by 1.4%, that of Specialist Palliative care by 10.6%, that of Cystic 
Fibrosis by 7.8% and that of Cancer Multi-Disciplinary Team Meetings activity by 12.1% between 2013/14 and 2014/15. 
 
Taken together, the Laspeyres output growth measure for Specialist Services increased by 0.61% 
between 2013/14 and 2014/15. 
 
2.3.10 Other Reference Cost activities 
Other types of activity reported in the Reference Costs are summarised in Table 23. The way of 
classifying these activities has changed somewhat over time, so rarely are the series recorded in a 
consistent fashion across all years.  Recording of some types of activity is occasionally discontinued, 
or subsumed under other broad categories.  
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Table 23: Regular admissions, ward attenders and day care 
Year 
Regular day and night 
admissions 
Audiological services Day care facilities 
Hospital at 
home/Early discharge 
schemes 
 Volume of 
activity 
Average 
cost (£) 
Volume of 
activity 
Average 
cost (£) 
Volume of 
activity 
Average 
cost (£) 
Volume of 
activity 
Average 
cost (£) 
2004/05 122,447 248 1,902,390 41 735,070 124 434,698 73 
2005/06 177,131 245 1,692,721 40 649,963 131 593,586 60 
2006/07 179,927 271 2,905,175 50 439,932 135 470,737 74 
2007/08 164,651 324 3,447,049 51 384,048 137 405,271 73 
2008/09 198,573 341 3,716,333 51 345,371 159 522,047 68 
2009/10 152,079 393 3,807,539 52 319,706 156 495,961 81 
2010/11 176,169 431 3,927,780 51 321,386 148 364,352 91 
2011/12 176,877 428 4,033,290 50 275,819 140 323,213 113 
2012/13 210,984 371 4,030,693 52 237,040 157 285,754 108 
2013/14 204,831 400 3,483,549 55 239,032 146 - - 
2014/15 223,302 355 2,918,029 60 266,333 131 - - 
 
Regular Day and Night Admissions (RDNA) activity has seen some change in the coding, with about 
53% of 2014/15 activity already being recorded in 2013/14.  There has been no change in coding for 
both Audiological Services and Day Care Facilities.  The total volume of RDNA activity increased by 
9%, whilst that of patients treated in Day Care Facilities increased by 11.4% between 2013/14 and 
2014/15.  The total volume of Audiological Services decreased by 16.2% between 2013/14 and 
2014/15.  Hospital at Home services are now captured under Community Intermediate Care 
activities in the community care setting. 
 
The Cost-ǁĞŝŐŚƚĞĚŽƵƚƉƵƚŐƌŽǁƚŚŵĞĂƐƵƌĞĨŽƌ ?KƚŚĞƌE,^ĂĐƚŝǀŝƚǇ ?ŝncreased by 1.45% between 
2013/14 and 2014/15. 
 
2.3.11 Total Reference Cost growth 
Including outpatient data, the activities recorded in the Reference Cost returns grew by 3.64% 
from 2013/14 to 2014/15.  The growth was mainly a result of the larger categories (A&E and Mental 
Health) growing at around 3% or more, and with Chemotherapy, Radiotherapy and High Cost Drugs 
growing at 16.34%.  Excluding Outpatient activity, the data contained in the Reference Cost returns 
suggest that output grew by 3.61% from 2013/14 and 2014/15.  
 
 Dentistry and ophthalmology 2.4
Information about dentistry is derived from the NHS Digital website
8 
with dental activity 
differentiated into dental bands, as shown in Table 24.
                                                          
8
 http://content.digital.nhs.uk/catalogue/PUB18129 
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Table 24: Dental services 
Year Dentistry  
 Band 1 Band 2 Band 3 Urgent Other Total 
 Volume of 
activity 
Average 
cost (£) 
 
Volume of 
activity 
Average 
cost (£) 
Volume 
of activity 
Average 
cost (£) 
Volume 
of activity 
Average 
cost (£) 
Volume 
of 
activity 
Average 
cost (£) 
 
2004/05
*
           2,241,095,331 
2005/06
*
           2,433,471,413 
2006/07 19,012.890 16 10,687.669 42 1,529.129 189 2,881.205 16 939.871 16 1,096,089,020 
2007/08 19,275,334 17 10,991,870 46 1,684,537 198 3,133,209 17 901,975 17 1,219,391,145 
2008/09 19,803,371 17 11,489,585 46 1,859,524 198 3,343,459 17 930,279 17 1,289,383,127 
2009/10 20,346,012 17 11,699,635 46 2,086,179 198 3,509,055 17 948,634 17 1,355,827,865 
2010/11 20,718,874 17 11,804,774 46 2,187,483 198 3,615,027 17 918,371 17 1,388,081,816 
2011/12 20,886,648 17 11,862,329 46 2,217,060 198 3,685,411 17 919,217 17 1,400,506,136 
2012/13 21,016,444 18 11,750,849 48 2,239,287 209 3,712,031 18 603,054 18 1,475,353,493 
2013/14 21,685,314 18 11,801,493 49 2,232,243 214 3,852,470 18 190,216 18 1,519,077,159 
2014/15 22,028.232 19 11,446.920 51 2,177.960 219 3,780.401 19 178.531 19 1,535,805,234 
Note: Total value of dentistry activity for years 2004/05 and 2005/06 is not directly comparable to following years, as it comes from a different data source (DH) 
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As shown in Figure 9, dental output went down in Bands 2 and 3, and for hƌŐĞŶƚĂŶĚ ?KƚŚĞƌ ?
dental care in the financial year 2014/15 compared to 2013/14.  Overall, the value of dental 
activity decreased between the two years as shown by its Laspeyres growth rate, which is -1.6% 
for this period. 
 
 
Figure 9: Number of courses of treatments (CoT) over time 
 
Data about the volume of activity for ophthalmology is published by NHS Digital on a bi-annual 
basis.
9
 Table 25 presents the volume of activity and cost for ophthalmic services over time. 
 
Table 25: Volume and average cost in ophthalmology 
Year Ophthalmology 
 Volume of activity Average cost 
(£)  
2004/05 10,148,978 33 
2005/06 10,354,682 35 
2006/07 10,484,922 36 
2007/08 11,047,890 28 
2008/09 11,278,474 28 
2009/10 11,811,651 28 
2010/11 11,938,529 28 
2011/12 12,305,727 28 
2012/13 12,339,253 28 
2013/14 12,787,430 28 
2014/15 12,764,485 28 
 
There was a very small decrease in ophthalmic activity between the financial years 2013/14 and 
2014/15, with cost-weighted output growth equal to -0.2%. 
 
 
                                                          
9
 http://content.digital.nhs.uk/article/2021/Website-
Search?productid=21325&q=a+guide+to+NHS+eye+care&sort=Relevance&size=10&page=1&area=both#top 
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 Primary care activity10 2.5
The data we have used to measure the volume of primary care consultations have changed over 
time, as summarised below. 
 
Table 26: CHE primary care evidence sources 
Year Activity Source Cost source 
2004/05-2008/09 QResearch 
PSSRU cost estimates 2008/09-2009/10 General Lifestyle Survey 
2009/10 -current  GP Patient Survey 
 
As with other types of healthcare output, primary care consultations are divided into a subset of 
activity, here based on location (surgery, home, phone) and type of contact (GP, practice nurse, 
other).  Up until 2008/09, we use data from QResearch (QR) as the basis for measuring primary care 
output (Fenty et al., 2006). 
 
&ƌŽŵ ? ? ? ? ? ? ? ?, ?ƐƐŽƵƌĐĞ of primary care data switched to survey based measures: initially the 
General Lifestyle Survey (GLS), but from 2010/2011 onwards, the GP Patient Survey (GPPS).  
Although the switch was forced by the lack of access to QResearch, there is some benefit in basing 
activity estimates on a sample which is weighted to be representative of the general population, 
rather than having a sample which is merely thought to be broadly representative.  There are, of 
course, major disadvantages of the survey approach, including a smaller sample (1.5 million patients 
as opposed to 9 million) but, more importantly, there is less detail in the survey data.  In the GP 
Patient Survey, patients are asked only when they last had any contact with their GP or nurse within 
discrete time frames.  These responses are then extrapolated to reflect a number of contacts over 
the course of a year.  In addition, there are no data on the type of contacts and so the distribution of 
contacts as observed in the 2008/09 QResearch data has been assumed ever since. 
 
Our method assumes that the estimate of consultation rate (i.e the ratio of consultations to 
population) for 2008/09, derived from QResearch, is reliable. We do not have access to QResearch 
for later years, but as is normal in construction of a Laspeyres index we estimate subsequent years 
by estimating the percentage change in each successive pair of years. For 2009/10, the General 
Lifestyle Survey suggested that there was no change in the rate of consultations. For years from then 
until 2013/14 we use GPPS data and look at the change in the percentage of respondents saying that 
they had seen their GP in the preceding 3 months. Beyond 2013/14, we additionally take account of 
the change in the percentage of respondents saying that they had seen or spoken to a practice nurse 
in the preceding 3 months (and for 2014/15 we also look at different growth rates for each 
age/gender group).   This formulation is as follows: 
 ݔ෤௧ ൌ  ݌௧݌௧ିଵ ݔ෤௧ିଵ 
 
Here, ݔ෤௧is the estimated number of GP or nurse observations in year t and pt is the proportion of 
individuals who have seen a GP or nurse in the last 3 months in year t.  The baseline for the number 
of consultations is 2008/09, this being the last year in which there was a QResearch measure of the 
number of consultations. Since then the GLS or GPPS ratios have been applied year-by-year to obtain 
annual estimates of the number of consultations in each subsequent year.  
 
                                                          
10
 An earlier published version of this report was subsequently found to contain an error in the calculation of primary care 
output growth. This error has now been corrected and the primary care figures, and those to which they contribute, have 
been revised. 
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These annual estimates are then uplifted to adjust for population growth. Between 2009/10 and 
2011/12 these adjustments were based on the UK population, from 2011/12 to 2013/14 the 
adjustments were based on the English population, and since 2013/14 they have been based on the 
English population accounting for changes in age and gender composition. We now calculate 
population growth ߜ௧௜ for each of the 5-year age/gender groups and use this to adjust the estimated 
number of GP and nurse observations according to the following formula:  
 ݔ෤௧௜ߜ௧௜ ൌ ݔ௧௜ 
 
As can be seen in Figure 10, there has been a shift in the age of population which is now older.  This 
also implies an increase in the number of consultations, as older people tend to have more 
consultations in a year. 
 
 
Figure 10: Population characteristics 
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Table 27: CHE GPPS based measure of volume of consultations 
Year 
Patients who 
report having 
seen a GP in 
previous 3 
months 
Patients 
who 
report 
having 
seen a 
nurse in 
previous 3 
months 
Number of 
consultations 
Population 
adjusted 
number of 
consultations 
Quality and 
population 
adjusted 
number of 
consultations 
QR      
2004/05    265,600 274,122 
2005/06    283,100 293,733 
2006/07    293,000 305,517 
2007/08    292,500 305,291 
2008/09    300,400 313,815 
GLS      
2009/10 53.55%  300,400 300,400 313,988 
GPPS      
2010/11 52.37%  293,517  303,355 
2011/12 54.00%  303,820  317,893 
Population Adjustment*     
2011/12 54.00%  303,764 319,661 334,468 
2012/13 54.83%  308,433 327,301 342,667 
2013/14 54.28%  305,328 328,199 343,942 
Age & Gender Adjustment     
2013/14** 54.28% 35.91% 301,253 314,366 329,415 
2014/15** 53.28% 35.86% 298,024 313,865 328,965 
Notes:  
*The population-adjustments are based on estimates for England only, and since 2013/14 these have also been adjusted for 
age and gender.  
 ? ?hƉƚŽ ? ? ? ? ? ? ? ?ƚŚĞŶƵŵďĞƌŽĨĐŽŶƐƵůƚĂƚŝŽŶƐǁĂƐďĂƐĞĚŽŶƚŚŽƐĞƌĞƉŽƌƚŝŶŐƚŚĞǇ ?ĚƐĞĞŶĂGP within the previous 3 
months. For 2013/14 -  ? ? ? ? ? ? ? ?ƚŚĞŶƵŵďĞƌĂůƐŽŝŶĐůƵĚĞƐƚŚŽƐĞǁŚŽ ?ĚƐĞĞŶĂƉƌŝŵ ƌǇĐĂƌĞŶƵƌƐĞ ?As a baseline, this 
calculation also takes the number of consultations reported by QResearch for the 2008/09 financial rather than calendar 
year (303,900,000) (http://content.digital.nhs.uk/pubs/gpcons95-09). This is the baseline used in other estimates of primary 
care activity, reviewed in Appendix B. 
 
The numbers of primary care consultations reported in Table 27 are those that were used to 
construct the year-on-year growth in primary care output as published in our successive NHS 
productivity reports. The figures do not, therefore, constitute a consistent historic series and should 
not be interpreted or used as such. 
 
The total number of consultations is broken down into types of consultations by using the relative 
shares as measured by QResearch in 2008/09.  Cost information for different types of consultation is 
derived from the PSSRU Unit Costs of Health and Social Care publication, as shown in Table 28 
(Curtis, 2014). 
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Table 28: PSSRU unit costs for consultation types (£) 
Year GP Home visit GP Telephone GP Surgery GP Other Practice Nurse Other Consultations 
2004/05 69 30 24 24 10 15 
2005/06 69 27 24 24 10 15 
2006/07 55 21 34 34 9 14 
2007/08 58 22 36 36 11 15 
2008/09 117 21 35 35 11 14 
2009/10 120 22 36 36 12 17 
2010/11 121 22 36 36 13 25 
2011/12 110 26 43 43 14 25 
2012/13 114 27 45 45 13 25 
2013/14 114 28 46 46 14 25 
2014/15 114 27 44 44 14 25 
 
We account for changes in the quality of primary care activity using the following Quality & 
Outcomes Framework (QOF) achievement indicators for the following conditions (Derbyshire et al., 
2007): 
 
1. Coronary heart disease (CHD002)  
2. Stroke (STIA003)  
3. Hypertension (HYP006) 
 
The numbers for prevalence are obtained from Annex 1 of the QOF report.
11
 Data about success 
rates are obtained from the Clinical results tables, available in the same report. These data are 
summarised in Table 29.  
 
Table 29: Quality adjustment for primary care (%) 
Year Prevalence QOF achievement 
 CHD Stroke Hypertension CHD Stroke Hypertension 
2004/05 3.57 1.63 10.41 78.60 73.13 64.33 
2005/06 3.57 1.66 11.48 84.44 81.22 71.05 
2006/07 3.54 1.61 12.49 88.86 86.92 77.62 
2007/08 3.50 1.63 12.79 89.41 87.51 78.35 
2008/09 3.47 1.66 13.13 89.68 87.88 78.56 
2009/10 3.44 1.68 13.35 89.77 88.12 78.72 
2010/11 3.40 1.71 13.52 90.16 88.57 79.30 
2011/12 3.38 1.74 13.63 90.14 88.61 79.65 
2012/13 3.40 1.70 13.68 90.57 89.26 80.79 
2013/14 3.29 1.72 13.73 91.27 89.84 83.09 
2014/15 3.25 1.73 13.79 91.98 88.17 83.61 
                                                          
11
 http://content.digital.nhs.uk/catalogue/PUB18887 
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The Laspeyres growth rates for primary care are reported in Table 30. 
 
Table 30: Laspeyres growth rates for primary care 
Years 
Unadjusted 
Growth rate 
Population adjusted 
growth rate 
Population and quality adjusted 
growth rate 
2004/05-2005/06  6.59% 7.15% 
2005/06-2006/07  3.50% 4.01% 
2006/07-2007/08  -0.17% -0.07% 
2007/08-2008/09  2.70% 2.79% 
2008/09-2009/10  0.00% 0.06% 
2009/10 - 2010/11 -2.29%  -3.39% 
2010/11 - 2011/12 3.51%  4.79% 
2011/12 - 2012/13 1.54% 2.39% 2.45% 
2012/13 - 2013/14 -1.01% 0.27% 0.37% 
2013/14 - 2014/15* -1.07% -0.16% -0.14% 
 
The survey data suggest that the number of primary care consultations decreased by -1.07% 
between 2013/14 and 2014/15. Scaled up to account for population growth, the growth in primary 
care activity amounts to -0.16%.  Finally, after taking account of the net, albeit small, 
improvements in the quality of consultations over these two years, the growth in primary care 
consultations amounts to -0.14%. 
 
 Community prescribing 2.6
Data about community prescribing are derived from the Prescription Cost Analysis (PCA) system, 
supplied by the Prescription Pricing Authority via the NHS Digital Prescription Drugs Team.  The data 
are based on a full analysis of all prescriptions dispensed in the community, summarised into 
different categories defined according to chemical composition.  The data include information about 
the Drug code (PropGenLinkCode), Net Ingredient Cost (NIC), Quantity of Drug Dispensed, and 
Number of Prescription Items.  The data are complete and prices are available for all items across 
the years.  
 
In February 2017 NHS Digital reported omissions in prescribing data previously released for the 
financial years 2012/13, 2013/14 and 2014/15. These omissions are due to some changes in the data 
extraction process. The omitted drug items accounted for 0.2%, 0.8% of the total prescription items 
for the financial years 2012/13 and 2013/14 respectively.  
 
Table 31 reports summary statistics about community prescribing. For the financial year 2013/14, 
we report two sets of figures: the first figure was used to construct the output and productivity 
growth figures for 2012/13  W 2013/14, the second to calculate the growth figures for 2013/14  W 
2014/15 based on NHS Digital ?ƐƌĞǀŝƐĞĚĨŝŐƵƌĞƐ.  Drugs are categorised according to their chemical 
composition and the number of category changes throughout the years, with the peak in 2004/05 
(8,779 categories), falling to a low in 2013/14 (7,809 categories).  Variations in the number of 
categories are usually due to zero counts in some years, rather than definitional changes. 
 
The 2014/15 data contain information on 7,926 distinct community prescribed drug items 
representing over a billion prescriptions with a total value/cost of approximately £8.9 billion, which 
is almost £240m more than in 2013/14.  There are 736 new drug items totalling £13.8m that appear 
32  CHE Research Paper 146 
in 2014/15 but not 2013/14.  There are 619 drug items which appeared in 2013/14 but not in 
2014/15, with a lagged total spend of £4m.  There are no data items which appear obviously 
incorrect and we therefore take the data at face value. 
 
Table 31: Community prescribing, summary data 
Year Unique 
drug codes 
observed 
Total Prescribing Total Spend 
Activity 
weighted 
average 
prescription 
unit cost (£) 
 
2004/05 8,779 691,948,868 £8,094,174,944 11.7 
2005/06 8,535 733,010,929 £8,013,483,226 10.93 
2006/07 8,218 762,631,738 £8,250,323,893 10.82 
2007/08 8,769 803,297,137 £8,303,500,918 10.34 
2008/09 8,276 852,482,281 £8,376,264,432 9.83 
2009/10 8,072 897,727,347 £8,621,421,130 9.6 
2010/11 7,860 936,743,859 £8,880,735,344 9.48 
2011/12 7,856 973,381,568 £8,777,964,802 9.02 
     
2012/13 7,699 1,001,825,994 £8,397,492,181 8.38 
2013/14 7,353 1,031,703,347 £8,540,423,964 8.28 
2013/14
*
 7,809 1,039,535,998 £8,703,169,718 8.37 
2014/15 7,926 1,071,065,672 £8,942,734,216 8.35 
Note: 
*
 In February 2017, NHS Digital released a new set of prescribing data to include previously omitted drug codes. The 
2012/13-2013/14 growth figures for prescribing are based on the earlier data; whilst the 2013/14-2014/15 growth figures 
are based on the new data. 
 
From the data we can observe changes in average cost of prescription and in unit (i.e. item) cost 
over recent years (Table 31).  Output and price indices for community prescribing are reported in 
Table 32.  Prices have fallen year-on-year over the whole period, the drop is minimal between 
2013/14 and 2014/15, being equal to -0.2%, a smaller decrease than that recorded in previous years. 
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Table 32: Community prescribing: price and volume growth 
Years Paasche Price Ratio Laspeyres Volume Ratio 
2004/05 - 2005/06 0.9014 1.0984 
2005/06 - 2006/07 0.9659 1.0659 
2006/07 - 2007/08 0.9376 1.0735 
2007/08 - 2008/09 0.9485 1.0636 
2008/09 - 2009/10 0.9626 1.0693 
2009/10 - 2010/11 0.9833 1.0476 
2010/11 - 2011/12 0.9564 1.0335 
2011/12 - 2012/13 0.9284 1.0356 
2012/13 - 2013/14  0.9855 1.032 
2013/14 - 2014/15* 0.9869 1.0411 
Note: 
*
 In February 2017, NHS Digital released a new set of prescribing data to include previously omitted drug codes. The 
2012/13-2013/14 growth figures for prescribing are based on the earlier data; whilst the 2013/14-2014/15 growth figures 
are based on the new data. 
 
The Laspeyres growth in the volume of prescriptions has increased annually, the most recent year-
on-year increase amounting to 4.11%. 
 
Taking the base year as 2004/05, trends in the volume and prices of pharmaceuticals are shown in 
Figure 11. 
  
Figure 11: Price and volume changes for community prescribed pharmaceuticals 
 
 Output growth 2.7
Output growth is measured by combining activities of different types into a single index, using costs 
to reflect their values.  As shown in Table 33 this generates our cost-weighted output growth 
index, which increased by 2.53% between 2013/14 and 2014/15. 
 
We then re-scale each type of cost-weighted output according to changes in survival, health 
improvements, waiting times, and blood pressure monitoring.  This generates our quality-adjusted 
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index, which increased by 2.49% between 2013/14 and 2014/15. This is slightly (0.04%) lower than 
the cost-weighted index. This is because there were improvements in some of the quality measures 
and deteriorations in others, the net effect being a slight overall reduction in quality. 
 
Table 33: Output growth 
Years All NHS 
 Cost-weighted  
growth 
Quality adjusted  
CW growth 
2004/05  W 2005/06 6.53% 7.11% 
2005/06  W 2006/07 5.88% 6.50% 
2006/07  W 2007/08 3.41% 3.66% 
2007/08  W 2008/09 5.34% 5.73% 
2008/09  W 2009/10 3.44% 4.11% 
2009/10  W 2010/11 3.61% 4.57% 
2010/11  W 2011/12 2.38% 3.15% 
2011/12  W 2012/13 2.58% 2.34% 
2012/13  W 2013/14 2.37% 2.64% 
2013/14  W 2014/15 2.53% 2.49% 
 
2.7.1 Contribution by settings 
Not all settings contribute equally to the output index.  Figure 12 shows the share of overall spend 
for each of the settings as well as contribution to growth, calculated as a share of overall spend 
multiplied by the output growth of the setting.  More detailed information on contribution of each 
setting can be also found in Table 34. 
 
By far the largest contributor to the output index is HES activity, with a share of over 30% of both 
total spend and overall output growth.  Other sizeable contributors are Primary care, Outpatient 
activity, Community prescribing and Community Mental Health.  All other settings contribute less 
than 6% to total spend or output. 
 
 
Figure 12: Contribution by setting, 2014/15  
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Table 34: Contribution of setting to growth, 2014/15 
Setting 
Setting specific 
growth 
Value of Activity (13/14 
prices) (£) 
Share of 
overall spend 
Contribution 
to growth** 
All HES
*
 1.73% 25,171,675,790 30.28% 30.80% 
Primary care
*
  -0.14% 11,439,141,636 13.76% 13.74% 
Outpatient
*
 3.51% 11,330,060,302 13.63% 14.11% 
Community Prescribing 4.11% 8,703,169,718 10.47% 10.90% 
Community Mental 
Health 
3.03% 6,297,089,549 7.57% 7.80% 
Community care  0.22% 4,864,684,367 5.85% 5.86% 
A&E 4.17% 3,923,106,579 4.72% 4.92% 
Specialist Services 0.61% 3,029,501,661 3.64% 3.67% 
Chemotherapy 
/Radiotheraphy/High 
Cost Drugs 
16.34% 2,902,935,540 3.49% 4.06% 
Ophthalmology & 
Dentistry 
-1.33% 1,870,731,484 2.25% 2.22% 
Diagnostic Tests -0.27% 964,981,062 1.16% 1.16% 
Radiology 2.62% 904,796,391 1.09% 1.12% 
Rehabilitation 2.35% 893,588,640 1.07% 1.10% 
Renal Dialysis 2.43% 529,893,559 0.64% 0.65% 
Other 1.45% 308,704,451 0.37% 0.38% 
     
Total value of NHS 
output  
83,134,060,730   
 
Overall NHS output 
growth 
   2.49% 
*
All HES, Primary Care and Outpatient activity are quality adjusted. 
** The contribution of each setting to growth in 2014-15 is expressed as a percentage of the total output in 2013-14. 
Where numbers in this column are lower than numbers in the preceding column, this represents negative growth in output 
for that sector. 
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3 Inputs 
Inputs into the health care system consist of: 
 
x Labour, such as doctors, nurses, technicians and managers; 
x Materials and supplies, such as drugs and disposable items; 
x Capital, such as buildings and equipment with an asset life of more than a year. 
 
We construct a comprehensive index of input growth, using the workforce data and organisational 
accounts submitted by NHS organisations together with other forms of expenditure data.  These 
data are used to quantify the amount of all inputs used in the production of health care provided to 
NHS patients. 
 
For capital and materials we have only expenditure data, but labour data comes from two sources: 
expenditure data as well as staff numbers from the Electronic Staff Record (ESR).  We explore the 
growth consequences of using these alternative data sources about labour input.  We report 
estimates for two different formulations of the input index.  Our mixed index uses information about 
labour inputs recorded in the ESR and expenditure for everything else; our indirect method uses 
expenditure data for all types of input. 
 
 Direct labour  3.1
Up to 2006/07, we used data from the Workforce Census to count the number of staff working in 
the NHS.  But, since 2007/08 we use the ESR data to calculate growth in labour inputs.
12
  These data 
are obtained from the NHS iView database
13
 which draws data directly from the ESR, and combined 
Payroll and Human Resources system for the NHS.  The data contain numbers of full time equivalent 
(FTEs) staff and earnings for over 580 different occupational groups for all staff employed by NHS 
organisations.
14
  Where 5 or less staff members are employed in a particular staff group, the 
organisation randomly reports either 5 or 0.  For this reason, the reported total number of staff 
constructed using the ESR source data differs from the aggregated figures published by NHS Digital 
(formerly the HSCIC).
15
 
 
Data on staff earnings come from a separate dataset, also provided by NHS Digital, which includes all 
earnings data submitted by NHS organisations for staff paid directly by the NHS.  This dataset 
contains average earnings by occupational group.
16
 In our calculation we sum basic and non-basic 
pay to get total earnings for each particular staff group.  As non-basic pay is no longer reported by 
FTEs, but only by headcount, we multiply that number first by an FTE/headcount ratio to get the 
equivalent FTE number (as advised by NHS Digital). 
 
Gradually more and more Clinical Commissioning Groups (CCGs) have been reporting ESR data, 
although 10 CCGs out of 212 are still not doing so (Table 35).  The inconsistent coverage over time 
raises some issues regarding the use of ESR as a measure of labour input.  For example, whilst not all 
Trusts have used the ESR (e.g. Isle of Wight), it has previously been assumed that the growth in 
staffing observed by Trusts within the ESR is representative of that in Trusts not submitting ESR data.  
However, when there are new types of organisation altogether this assumption may become 
untenable. 
                                                          
12
 We excluded one organisation from the ESR data reported in 2011/12 that had not appeared in previous years. 
13
 http://content.digital.nhs.uk/iview 
14
 tĞ ĚƌŽƉ ^Z ƌĞƚƵƌŶƐ ŵĂĚĞ ďǇ ƉƌŝǀĂƚĞ ƉƌŽǀŝĚĞƌƐ ? E,^ ƌŵ ?Ɛ-length bodies, Special Health Authorities and other NHS 
bodies that report to the ESR but do not fall in the included categories (e.g. Sussex Health Informatics Service (YDD81) ) 
15
 http://content.digital.nhs.uk/workforce.  
16
 In the past we had information on total earnings per month, without separation in basic/non-basic. 
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Table 35: Number of reporting entities by organisation type 
Organisation type 2010/11 2011/12 2012/13 2013/14 2014/15 
CCGs n/a n/a 9 152 202 
CSUs 0 0 0 24 25 
NHS England 0 0 1 1 1 
Non-geographical staff 0 1 1 1 1 
PCTs 147 142 132 40 26 
SHA 10 10 10 2 0 
NHS Trusts 248 260 260 251 249 
Note: CCGs: Clinical Commissioning Groups; CSUs: Commissioning Support Units; Non-Geographic Central Staff, code AHO; 
PCTs: Primary Care Trusts; SHA: Strategic Health Authorities; n/a not applicable 
 
Table 36 shows expenditure by organisational type as determined by the summed product of staff 
group FTEs and average earnings.  It also illustrates the impact that the NHS re-organisation has had 
on the apparent distribution of labour expenditure over time, especially with the shift of staff from 
PCTs to Trusts. 
 
Table 36: Expenditure on labour in current prices (£m) 
Organisation type 2010/11 (£) 2011/12 (£) 2012/13 (£) 2013/14 (£) 2014/15 (£) 
CCGs 0 0 7 434 535 
CSUs 0 0 0 318 306 
NHS England 0 0 1 221 205 
Non-geographical staff 0 157 143 76 71 
PCTs 5,822 3,742 1,329 89 1 
SHA 133 114 110 0.4 0 
NHS Trusts 28,809 31,761 33,753 34,510 35,820 
 
The number of NHS staff, measured as Full Time Equivalents (FTEs), is reported in Table 37. Figure 13 
shows growth in (non-medical) labour input from the base year 2007/08. Although not reported in 
ESR data, we include information about the numbers of GPs and practice staff for completeness, 
with data taken from the Workforce Census, and use expenditure data to capture growth in these 
types of staff. 
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Table 37: NHS staff numbers 
 2004/5 2005/6 2006/7 2007/8 2008/9 2009/10 2010/11 2011/12 2012/13 2013/14 2014/15 
GPs
a
 31,021 32,855 33,384 33,730 34,043 36,085 35,243 35,319 35,871 36,294 n/a 
GP Practice staff 69,140 72,006 72,990 75,085 73,292 72,153 73,306     
GP Practice staff  ? new method       82,802 84,609 85,546 87,114 n/a 
Medical staff
b
 78,462 82,568 85,975 84,811 90,460 93,393 95,531 99,331 100,878 100,797 104,189 
Ambulance staff    21,149 23,084 24,489 25,056 24,908 24,566 24,757 25,381 
Administration and estates staff    237,264 243,018 262,479 263,723 250,539 242,980 239,359 245,504 
Health care assistants and other 
support staff 
   101,114 106,406 112,710 114,786 116,643 116,018 119,138 123,870 
Nursing, midwifery and health 
visiting staff and learners 
   366,520 372,132 379,841 380,114 377,948 363,781 366,246 372,060 
Scientific, therapeutic and technical 
staff and healthcare scientists 
   141,754 150,056 159,538 165,454 168,750 164,312 165,683 173,536 
Unknown and Non-funded staff    4,327 3,595 3,462 3,351 3,055 2,652 2,423 0 
Professionally qualified clinical staff 412,013 425,044 425,983 
    
    
Support to clinical staff 271,347 278,994 273,202 
    
    
NHS infrastructure support staff 178,530 186,510 178,230 
    
    
Volume Index FTE  3.60% -0.76% -0.37% 2.85% 4.39% 1.91% -0.43% -2.11% 0.72% 2.27% 
Labour Index  3.44% 0.64% 0.64% 4.22% 4.55% 1.29% -0.24% -1.95% 0.38% 2.80% 
Notes: 
a
 Data for GPs and GP practice staff are not available from ESR; Workforce Census data are used instead; there were also changes in counting of GP Practice staff, therefore data from 2010/11 
onwards are not comparable to previous years. NHS Digital stopped reporting the GP figures in 2014/15. 
b
 FTE data up to 2006/07 are taken from the Workforce Census data. FTE data from 2007/08 onwards are taken from organisational returns of Electronic Staff Records. When there are 5 or less 
people employed in an occupational group, organisations report either 5 or 0; these totals therefore will differ from those derived from national level data 
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Figure 13: Growth in non-medical staff 
 
Table 38: Growth in direct labour 
Years Nominal expenditure growth Laspeyres volume growth 
 All* Trusts All* Trusts 
2007/08  ? 2008/09 7.61% 7.21% 4.14% 3.77% 
2008/09  ? 2009/10 7.03% 6.55% 4.54% 4.15% 
2009/10  ? 2010/11 2.62% 3.70% 1.42% 2.95% 
2010/11  ? 2011/12 2.91% 10.25% 0.1% 7.26% 
2011/12  ? 2012/13 -1.21% 6.27% -1.97% 5.5% 
2012/13  ? 2013/14 0.87% 2.24% 0.38% 1.71% 
2013/14  ? 2014/15 3.67% 3.80% 2.80% 2.92% 
*all organisations reporting to ESR except independent providers; arms-length bodies and special health authorities 
 
Table 38 shows the growth in nominal expenditure and the Laspeyres input growth over time by all 
organisations submitting ESR data (i.e. Trusts plus PCTs, CCGs, CSUs, NHS England, SHAs and the 
non-geographical category) and hospital Trusts only.  As expected, due to wage inflation, the 
Laspeyres direct labour input growth is always smaller than the nominal growth.  Of note, however, 
is the consistently positive growth in the Trusts only measure and, in particular, the large growth 
from 2010/11 to 2012/13, which is attributable to the transfer of PCT staff to Trusts via the 
 ‘dƌĂŶƐĨŽƌŵŝŶŐŽŵŵƵŶŝƚǇ^ĞƌǀŝĐĞƐ ?ŝŶŝƚŝĂƚŝǀĞ ?17  As Trusts now employ the majority of staff, the 
hospital Trusts only ŐƌŽǁƚŚƌĂƚĞĂŶĚƚŚĞ “Aůů ?ŐƌŽǁƚŚƌĂƚĞůŽŽŬŵŽƌĞƐŝŵŝůĂƌ ?
 
                                                          
17
 https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/229996/Annual_Report.pdf  
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At 2.80%, the growth rate for labour between 2013/14 and 2014/15 is greater than in previous 
years.  This may be a consequence of the several reports coming out in 2012/13 advising that higher 
staffing ratios be adopted, namely the Keogh and Berwick reports, and the Francis Inquiry (the latter 
dealing with poor level of care in the Mid Staffordshire Trust).  The reports had a lagged impact, with 
an upward trend only really observable from September 2013 as shown in Figure 14. 
 
 
Figure 14: Changes in number of FTEs in different categories by month 
 
 Expenditure data 3.2
The source of expenditure data has changed over time and by type of organisation, as summarised 
in Table 39.  Data for Foundation Trusts are derived from the Consolidated NHS Financial Trust 
Accounts, the format of which has remained unchanged over the past decade.  These accounts are 
less detailed than Trust Financial Returns (TFRs), which were reported by NHS Trusts, PCTs and SHAs 
up to and including 2011/12.  These provided a detailed breakdown of expenditure on different 
types of NHS and agency staff, materials and capital items. 
 
The TFRs were discontinued in 2011/12 for PCTs and SHAs.  For expenditure data for these 
disbanding organisations we have relied on aggregated information as reported in the DH Annual 
Report and Accounts.
18
 
 
For NHS Trusts, TFRs were subsequently replaced with Financial Monitoring and Accounts, although 
both reporting systems were used in 2011/12.  The Financial Monitoring and Accounts are much less 
detailed than the TFRs, reporting information for very broad input categories, making it no longer 
possible to report time series for specific input types.  For instance, it is not possible to identify 
expenditure by NHS Trusts on agency staff from this information.
19
 Instead, we rely on data provided 
directly by the Department of Health to identify expenditure on agency staff.
20
 
  
                                                          
18
 https://www.gov.uk/government/publications/department-of-health-annual-report-and-accounts-2015-to-2016  
19
 http://www.parliament.uk/business/publications/written-questions-answers-statements/written-
question/Commons/2014-10-22/211600/ 
20
 For both 2013/14 and 2014/15 the total number of FTEs for agency staff used by Foundation Trusts 
(https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/447099/50702_HC_238_WEB.pdf) is 
available; however, since it is only an aggregate number, we cannot use it in the direct calculation of labour input growth.  
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Table 39: Source of financial information 
Years 
Foundation 
Trusts 
NHS Trusts PCT/SHAs 
NHS 
England/CSUs/CCGs 
2004/05 - 2011/12  Trust Financial 
Returns 
PCT/SHA Financial 
Returns 
N/A 
 
2011/12 - 2012/13 
Consolidated NHS 
Financial Trusts 
Accounts 
 
Financial Monitoring 
and Accounts 
DH Annual 
Reports and 
Accounts 
DH Annual Reports 
and Accounts 
2012/13 - 2014/15 N/A 
 
Other than loss of detail, the more aggregated data have two major implications for the construction 
of the input index: 
 
1. Rather than input-specific price deflators, we now have to apply deflators for each 
aggregated input category.  This may generate inaccuracy in distinguishing the contributions 
of changes in volume and prices to expenditure growth. 
 
2. The detail in the TFRs made it possible to account for utilisation of different types of capital 
in each period, albeit subject to various assumptions about asset life and depreciation 
(Street and Ward, 2009).  The annual accounts, however, do not identify all items of capital.  
This makes it impossible to ascertain how much has been spent on capital in each period, let 
alone how much of the capital acquired has been utilised. 
 
The financial reporting lines designated as materials and capital items in the most recent financial 
data are listed in Table 40 for NHS Trusts and PCTs/SHAs/other organisations, separately. 
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Table 40: Materials and capital items 
Organisation Materials Capital 
Foundation Trusts 
and NHS Trusts 
Source: 
Financial Monitoring 
& Accounts 
Consolidated NHS 
Financial Trusts 
Accounts 
Services from Other NHS Trusts 
Services from PCTs 
Services from Other NHS Bodies 
Services from Foundation Trusts 
Purchase of Healthcare from Non-NHS 
Bodies 
Supplies & Services - Clinical 
Supplies & Services - General 
Consultancy Services 
Transport 
Audit fees 
Other Auditors Remuneration  
Clinical Negligence 
Research & Development (excluding 
staff costs) 
Education & Training 
Establishment 
Other 
 
Premises 
Impairments & Reversals of Receivables 
Inventories write downs 
Depreciation 
Amortisation 
Impairments & Reversals of Property, Plant 
& Equipment 
Impairments & Reversals of Intangible 
Assets 
Impairments & Reversals of Financial Assets 
Impairments & Reversals for Non-Current 
Assets held for sale 
Impairments & Reversals for Investment 
Properties 
   
PCTs/SHAs/CCGs/NHS 
England Group 
Source:  
DH Annual Report & 
Accounts 
Consultancy Services 
Transport 
Clinical Negligence Costs 
Establishment 
Education, Training & Conferences 
Supplies & Services - Clinical 
Supplies & Services - General 
Inventories consumed 
Research & Development Expenditure 
Other 
Premises 
Impairment of Receivables 
Rentals under operating leases 
Depreciation 
Amortisation 
Impairments & reversals 
 
3.2.1 Input use derived from expenditure data 
Table 41 presents expenditure data reported by PCTs, CCGs and NHS England Group. Expenditure by 
PCTs had a huge drop in 2011/12, due to the reorganisation of the NHS and the transfer of staff from 
PCTs to hospital Trusts.  PCTs officially ceased to exist in 2013/14; their activity was partly taken over 
by CCGs, as well as by CSUs and NHS England, together forming the NHS England Group.  
 
It is not clear which activity was taken over by which organisation.  Unlike PCTs, CCGs do not provide 
clinical activity and it is unclear how the other new organisations share the work previously done by 
PCTs and SHAs. 
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Table 41: Current expenditure by PCTs and NHS England Group, (£000) 
Organisation Year Labour Materials Capital 
PCTs 2007/08 6,701,228 2,617,114 1,174,841 
2008/09 7,478,953 2,526,610 1,247,997 
2009/10 8,230,341 2,623,459 1,703,974 
2010/11 7,175,399 2,638,638 1,171,813 
2011/12 2,328,314 2,052,029 892,604 
2011/12* 2,358,373 860,860 1,721,795 
2012/13* 1,938,770 885,265 1,814,809 
NHS England Group 2013/14* 1,529,067 1,420,027 696,400 
 2014/15* 1,726,006 1,457,798 536,383 
* Data up to 2010/11 are taken from Financial Returns and from 2011/12 onwards from DH Annual Report and Accounts. 
Material and capital items are identified differently in each source 
 
Table 42 shows the expenditure for labour, materials and capital for hospital Trusts.  In current 
terms, labour expenditure increased by 3.3% between 2013/14 and 2014/15.  We also observe an 
increase in spend on materials of 2.3%, whilst capital spend decreases by 6.15% between 2013/14 
and 2014/15. 
 
Table 42: Current expenditure by hospital Trusts (£000) 
Year Labour Materials Capital 
2007/08 30,884,556 10,140,836 6,452,630 
2008/09 33,435,219 11,322,441 6,340,019 
2009/10 35,983,781 12,115,273 6,529,977 
2010/11 38,222,951 12,961,217 6,839,898 
2011/12 42,647,889 14,941,588 7,278,435 
2011/12* 42,701,684 17,477,370 12,097,485 
2012/13* 43,797,935 19,681,855 12,377,259 
2013/14* 45,360,562 21,108,612 13,217,703 
2014/15* 46,847,155 21,983,076 12,747,384 
* For NHS Trusts, data up to 2011/12 are derived from Financial Returns; for 2011/12 and following years data are derived 
from Financial Monitoring and Accounts. Material and capital items are identified differently in each source. 
 
The use of agency staff is subject to considerable year-on-year variation, as shown in Figure 15.  The 
substantial increase of 29% between 2013/14 and 2014/15 will contribute to increased overall input 
growth. 
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Figure 15: Trends in use of agency staff 
 
Table 43 presents current expenditures for the whole NHS. From 2013/14 onwards, we do not 
include spend for DH administration.  This is due to the restructuring of the NHS and changes to the 
DH responsibilities.  In order to compare like-with-like, we omitted this item of expenditure from the 
input growth calculations for the years 2012/13 to 2013/14.  The 2013/14 to 2014/15 calculations 
are unaffected. 
 
Table 43: Total NHS current expenditure (£000) 
Year NHS Staff Agency Material Capital Prescribing 
Primary 
Care 
DH Admin TOTAL 
2004/05 31,334,252 1,557,282 8,757,990 5,115,514 8,094,175 9,569,836 278,000 64,707,050 
2005/06 33,926,746 1,459,936 10,271,344 5,839,664 8,013,483 11,162,141 262,000 70,935,314 
2006/07 35,177,509 1,185,244 11,378,727 6,568,363 8,250,324 11,209,422 229,000 73,998,589 
2007/08 36,561,167 1,207,654 13,036,200 7,784,592 8,303,501 11,697,639 226,000 78,816,753 
2008/09 39,264,185 1,895,423 13,991,803 7,426,031 8,376,264 12,074,672 242,958 83,271,336 
2009/10 42,104,673 2,302,578 14,911,074 7,635,390 8,621,421 12,683,418 241,608 88,500,162 
2010/11 43,513,839 2,127,889 16,077,609 8,025,361 8,880,735 12,962,081 212,245 91,799,759 
2011/12 43,360,622 1,872,598 17,221,673 8,265,079 8,777,965 13,250,874 453,000 93,201,811 
2011/12* 43,457,477 1,862,385 19,154,991 13,892,358 8,777,965 13,250,874 453,000 100,849,049 
2012/13* 43,654,591 2,345,552 21,442,537 14,273,017 8,397,492 13,419,803 457,000 103,989,992 
2013/14* 44,310,698 2,578,931 22,528,639 13,914,103 8,540,424 13,294,670 n/a
 
105,167,465 
2013/14**     8,703,170   105,330,221 
2014/15** 45,239,355 3,333,806 23,440,874 13,283,767 8,942,734 13,460,552 n/a 107,701,088 
*For NHS Trusts, data from prior to 2011/12 from Financial Returns and from 2011/12 onwards data from Financial 
Monitoring and Accounts. Agency costs, material and capital items are identified differently in each source  
** In February 2017, NHS Digital released a new set of prescribing data to include previously omitted drug codes. The 
2013/14 and 2014/15 expenditure figure for prescribing are based on the new data. 
0
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 Input growth 3.3
Our measures of input growth are reported in Table 44, differentiated according to the use of the 
mixed or indirect index.  Estimates of input growth have generally been higher if using the mixed 
rather than the indirect input index.  This is also the case for 2013/14  W 2014/15, where the mixed 
index suggests a growth rate of 1.94%, while the indirect index suggests that an input growth rate 
of 1.52%.  This implies that growth in labour inputs between 2013/14 and 2014/15 is greater if using 
ESR rather than expenditure data. 
 
Table 44: Input growth 
Years All NHS 
 Mixed Indirect 
2004/05  W 2005/06 7.19% 7.10% 
2005/06  W 2006/07 1.92% 1.36% 
2006/07  W 2007/08 3.88% 3.70% 
2007/08  W 2008/09 4.23% 4.24% 
2008/09  W 2009/10 5.43% 5.83% 
2009/10  W 2010/11 1.33% 0.80% 
2010/11  W 2011/12 1.00% 0.75% 
2011/12  W 2012/13 1.98% 2.63% 
2012/12  W 2013/14 0.43% 0.55% 
2013/14  W 2014/15 1.94% 1.52% 
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4 Productivity growth 
Year-on-year productivity growth figures over the pair of years from 2004/05  W 2014/15 are 
provided in Table 45. These figures are constructed by comparing the quality-adjusted output 
growth rate, as reported in the final column of Table 33, with the estimates of mixed and indirect 
input growth, as reported in Table 44.  Productivity growth between 2013/14 and 2014/15 is 
estimated to have been 0.53% based on the mixed method, and 0.95% based on the indirect 
method. 
 
Table 45: Quality-adjusted productivity growth year-on-year 
Years All NHS 
 Mixed Indirect 
2004/05  ? 2005/06 -0.07% 0.01% 
2005/06  ? 2006/07 4.50% 5.07% 
2006/07  ? 2007/08 -0.21% -0.04% 
2007/08  ? 2008/09 1.44% 1.43% 
2008/09  ? 2009/10 -1.25% -1.63% 
2009/10  ? 2010/11 3.21% 3.74% 
2010/11  ? 2011/12 2.13% 2.38% 
2011/12  ? 2012/13 0.36% -0.28% 
2012/13  ? 2013/14 2.20% 2.07% 
2013/14  ? 2014/15 0.53% 0.95% 
 
We find that, if we use the mixed approach to capture input growth, year-on-year productivity 
growth has been positive since 2009/10.  A similar, but not identical, picture emerges if using the 
indirect measure, which sometimes suggests higher and sometimes lower changes in productivity.  
The differences are due to how labour input is measured, with different growth rates if using ESR 
data vs expenditure data. 
 
As can be observed in Figure 16, both input and output year-on-year growth rates generally show 
downward trends. Where the output line is above the input line the productivity growth is positive, 
in other cases it is negative.  
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Figure 16: Input and Output growth 
 
Figure 17 presents the input, output and productivity indices over time.  We observe slower growth 
in the input index, which is the main reason why productivity growth is positive.  
 
Figure 17 Trends in input, output and productivity growth 
 
The increasing productivity growth that we observe in the NHS over time is not observed in the rest 
of the economy.  Productivity is measured somewhat differently according to the nature of the data 
available for each sector of the economy, but the measures are otherwise equivalent.  The main 
measure produced by the Office of National Statistics is called Gross Value Added per hour worked,
21
 
which is used to measure the contribution to the economy of each sector in the United Kingdom.
22
 
                                                          
21
 http://www.ons.gov.uk/ons/guide-method/method-quality/specific/economy/national-accounts/gva/relationship-gva-
and-gdp/gross-value-added-and-gross-domestic-product.html 
22
http://www.ons.gov.uk/employmentandlabourmarket/peopleinwork/labourproductivity/datasets/labourproductivitytabl
es110andr1 
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The rate of NHS productivity growth since 2004/05 compares favourably with that achieved by the 
economy as a whole.  This is shown in the graph below, with NHS productivity growth outpacing the 
economy as a whole through the entire period.  The recession in 2008/09 is reflected by the notable 
dip in the two series.  Since then, NHS productivity has increased year-on-year, whereas whole 
economy productivity has been falling or been stable over the same time period.  From 2004/05 
total productivity growth was 13.64% for the NHS, compared to only 3.83% in the whole economy. 
 
 
Figure 18 Comparison of productivity growth in the NHS vs Whole Economy 
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5 Conclusions 
Total NHS productivity growth between 2013/14 and 2014/15 amounted to 0.53%, according to our 
preferred mixed method.  This positive year-on-year growth continues a sequence extending back to 
2009/10. 
 
Quality adjusted output growth between 2013/14 and 2014/15 amounted to 2.49% for the NHS as a 
whole, which is very similar to last year (2.64%), but lower than the average over the whole period 
(4.25%).  We observe positive growth across all settings, with the exception of Ophthalmology and 
Diagnostic Tests. Growth was substantial in both inpatient and outpatient settings, amounting to 
2.49% and 3.51%.  We observe high growth in the A&E attendances (4.17%) as well as across most of 
RC categories.  
 
Quality is captured by changes in survival following hospital admission, health status, life 
expectancy, waiting times, and blood pressure monitoring.  There were improvements in some of 
the quality measures and deteriorations in others, the net effect being a slight overall reduction in 
quality between 2013/14 and 2014/15. This reduces the output index by 0.04% compared to the 
cost-weighted output index. 
 
Our indirect measure of input growth indicates a growth between 2013/14 and 2014/15 of 1.52% 
and our mixed measure (using the direct measure of labour) is 1.94%.  Our usual base case measure 
uses the mixed method, as it is generally recommended to use direct measures of input whenever 
possible. 
 
Overall, we estimate productivity growth to be 0.95% using our indirect measure and 0.53% based 
on our preferred mixed method. 
 
In addition to our usual whole-NHS measurement we have also included a measurement for Trusts 
only, which is contained in Appendix A.3.  For Trusts we find output growth of 2.86% and a mixed 
input growth of 2.27%, leading to productivity growth of 0.58% between 2013/14 and 2014/15. 
 
While both our output and input measures are based on the most comprehensive data available, the 
usual caveat applies to data on primary care.  We continue to apply our standard approach of using 
survey data to estimate primary care activity.  Whilst primary care represents a sizable component 
of output (approximately 14%) and is therefore an important component of the measurement, use 
of survey data does not have any obvious sources of bias that may over- or under-estimate our 
estimate.  As a result, it is difficult to predict what effect better primary-care data may have on our 
estimates.  We have reviewed the alternative sources of data on which we might base estimates of 
primary care activity, and this review is included as Appendix B. 
 
The good news about continued positive NHS productivity growth is tempered by the claim that it is 
not enough to meet challenges of demand on the NHS over the foreseeable future; the NHS has 
been set a target of productivity improvements of 2-3% a year (NHS England, 2014).  This is higher 
than the annual average of 1.37% realised since 2004/05. However well the NHS has been doing, the 
pressure to do better remains. 
 
Nor might these recent productivity gains be sustainable.  They have been achieved mainly by 
restricting growth in staffing levels.  But staff numbers have increased in response to the Mid Staffs 
enquiry,
23
 and may do so further if the NHS is to extend the range of services it provides 7-days a 
week.
24
  The NHS, like the economy as whole, faces tough challenges in making continued 
productivity gains.  
                                                          
23
 https://theconversation.com/creating-new-criminal-offences-wont-help-nhs-patients-16825 
24
 https://theconversation.com/why-all-the-fuss-about-a-seven-day-nhs-50020 
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Appendix A 
A.1  Deflators 
We use various deflators to adjust our expenditure series, as shown in Table A1.  We use the 
Hospital and Community Health Services (HCHS) prices index for deflating the expenditure on capital 
and material goods.  For Primary Care expenditure, we use the HCHS pay and prices deflator, while 
we construct our own deflator for pharmaceutical expenditure.  For labour and agency staff we 
originally used the HCHS pay deflator.  The advent of the Electronic Staff Record data has allowed us 
to construct our own ESR pay deflator, which we have employed since 2011/12.  The HCHS and ESR 
pay deflators are usually quite similar. 
 
Table A1: Deflators used 
 Pay HCHS (ESR) 
deflator 
Prices deflator Pay and Prices 
deflator 
Pharmaceuticals 
2004/05 - 2005/06 4.7% 1.9% 3.7% -9.9% 
2005/06 - 2006/07 -1.1% 3.0% 3.7% -3.4% 
2006/07 - 2007/08 3.5% 1.8% 2.9% -6.2% 
2007/08 - 2008/09 3.0% (3.33%) 5.2% 3.9% -5.2% 
2008/09 - 2009/10 1.8% (2.38%) -1.3% 0.6% -3.7% 
2009/10 - 2010/11 3.1% (1.19%) 2.8% 3.0% -1.7% 
2010/11 - 2011/12 0.9% (2.8%) 4.1% 2.1% -4.4% 
2011/12 - 2012/13 0.9% (0.8%) 3.1% 1.7% -7.2% 
2012/13 - 2013/14 0.7% (0.5%) 1.8% 1.1% -1.5% 
2013/14 - 2014/15 0.3% (0.4%) 1.7% 0.9% -1.31% 
 
A.2  Technical details 
In calculating productivity growth for the health care system, it is necessary to combine the 
multitude of outputs and inputs into single measures for both outputs and inputs.  This requires the 
construction of an output growth index (ܺ) and an input growth index (ܼ), with total factor 
productivity growth  ?ܶܨ  ܲcalculated by comparing growth in outputs with growth in inputs such 
that:  
  ?ܶܨܲ ൌሾܺȀܼሿ െ  ?           (a1) 
 
In order to estimate total factor productivity, it is necessary to correctly define and measure the 
output and input indices. 
 
Output growth 
Quantification of health care output is a challenge because patients have varied health care 
requirements and receive very different packages of care.  To address this, it is necessary to classify 
patients into reasonably homogenous output groupings, such as Healthcare Resource Groups (HRGs) 
or Reference Cost (RC) categories.  Furthermore, in order to aggregate these diverse outputs into a 
single index, some means of assessing their relative value is required.  Usually prices are used to 
assess value, but prices are not available for the vast majority of NHS services for which people do 
not have to pay at point of use.  In common with the treatment of other non-market sectors of the 
economy in the national accounts, costs are used to indicate the value of health services. Costs 
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reflect producer rather than consumer valuations of outputs, but have the advantage of being 
readily available. 
 
ƐĐŽƐƚƐĂƌĞŶŽƚďĞůŝĞǀĞĚƚŽƚƌƵůǇƌĞĨůĞĐƚĐŽŶƐƵŵĞƌƐ ?ǀĂůƵĂƚŝŽŶƐ ?ƚŬŝŶƐŽŶƐƵŐŐĞƐƚƐƐƵƉƉůĞŵĞŶƚŝŶŐ
costs with information about the quality of non-market goods and services (Atkinson, 2010).  One 
way of doing this is by adding a scalar to the output index that captures changes over time in 
different dimensions of quality (Castelli et al., 2007).  Thus, following Castelli et al. (2007), the output 
growth index (in its Laspeyres form) can be calculated across two time periods as: 
 
    ሺܺ଴ǡ௧ሻ௖௤ ൌ  ? ௫ೕ೟௖ೕబቈೡೕబ೜ೕ೟೜ೕబ ቉಻ೕసభ ? ௫ೕబ௖ೕబ಻ೕసభ      (a2) 
 
We define ݔ௝  as the number of patients who have output type j, where jA? ? QJ; ௝ܿ௢ indicates the cost 
of output j; ݍ௝  represents a unit of quality for output j, and ݒ௝ is the value of this unit of quality; and 
t indicates time with 0 indicating the first period of the time series.  Our measures of quality include 
inpatient and outpatient waiting times, health improvements (limited to four conditions), survival 
rates following hospitalisation, and blood pressure management in primary care.  
 
Input growth 
Turning to the input growth index (ܼ), inputs into the health care system consist of labour, material 
goods and capital.  Growth in the use of these factors of production can be calculated directly or 
indirectly (OECD, 2001).  A direct measure of input growth can be calculated when data on the 
volume and price of inputs are available.  In its Laspeyres form, the input growth index can be 
calculated as: 
 ܼሺ଴ǡ௧ሻ஽ ൌ  ? ௭೙೟ఠ೙బ೙ಿసభ ? ௭೙బఠ೙బ೙ಿసభ        (a3) 
 
Where ݖ௡௧ is the volume of input of type n at time t and ߱௡௧ is the price of input type n at time t.  
 
However, data about the volume of inputs are rarely available.  It is, therefore, common practice to 
calculate input growth using expenditure data.  Changes in expenditure are driven by both changes 
in the volume of resource use and in prices.  Hence to isolate the volume effect, it is necessary to 
wash out pricĞĐŚĂŶŐĞƐďǇĐŽŶǀĞƌƚŝŶŐ ‘ĐƵƌƌĞŶƚ ?ŵŽŶĞƚĂƌǇǀĂůƵĞƐŝŶƚŽ ‘ĐŽŶƐƚĂŶƚ ?ĞǆƉĞŶĚŝƚƵƌĞƵƐŝŶŐĂ
deflator ߨ௡௧.  This deflator reflects the underlying trend in prices for the input in question, such that ߱௡௧ାଵ ൌ ߨ௡௧߱௡௧.  
 
If expenditure data and deflators are available, the input growth index can be specified as: 
 ܼሺ଴ǡ௧ሻூ௡ௗ ൌ  ? గ೙೟ா೙೟೙ಿసభ ? ா೙బ೙ಿసభ ൌ  ? ௭೙೟గ೙೟ఠ೙೟೙ಿసభ ? ௭೙బఠ೙బ೙ಿసభ ൌ  ? ௭೙೟ఠ೙బ೙ಿసభ ? ௭೙బఠ೙బ೙ಿసభ ൌ ܼሺ଴ǡ௧ሻ஽                  ሺ ?ሻ 
 
As shown, this is equivalent to using volume data, provided that deflators capture correctly the 
trend in prices for each input in question. 
 
Productivity growth 
The above equations show output or input growth over two periods from a base (0) to a current 
period (t).  Usually, there is interest in assessing productivity growth over longer periods of time.  
We do this by means of a chained index that involves updating weights in every period, thereby 
making it possible to account for ongoing changes in the composition of the outputs and inputs 
being measured (Diewert et al., 2010). 
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Using the Laspeyres output index as defined in eq. (a2), a chained output index takes the following 
form: 
 
ሺܺ଴ǡ்ሻ௖௤ ൌ  ? ௫ೕ೟௖ೕబቈೡೕబ೜ೕ೟೜ೕబ ቉಻ೕసభ ? ௫ೕబ௖ೕబ಻ೕసభ  ൈ   ? ௫ೕ೟శభ௖ೕ೟ቈೡೕ೟೜ೕ೟శభ೜ೕ೟ ቉಻ೕసభ  ? ௫ೕ೟௖ೕ೟಻ೕసభ ൈ ? ? ?ൈ ? ௫ೕ೅௖ೕ೅షభቈೡೕ೅೜ೕ೅೜ೕ೅షభ ቉಻ೕసభ ? ௫ೕ೅షభ௖ೕ೅షభ಻ೕసభ    (a5) 
 
This can be simplified as: 
 ሺܺ଴ǡ்ሻ௖ǡ௤ ൌ ሺܺ଴ǡ௧ሻ௖ǡ௤ ൈ ሺܺ௧ǡ௧ାଵሻ௖ǡ௤ ൈ ? ? ?ൈ ܺሺ்ିଵǡ்ሻ௖ǡ௤          (a6) 
 
where each link is represented by eq. (a2) for the relevant two consecutive years. An analogous 
construction applies to the chained input index. 
 
A.3 Trusts-only productivity measures 
While the main body of our text focuses on a full-NHS measure of productivity, we also produce 
estimates of Trusts-only productivity changes, and the components thereof. 
 
As shown in Table A2, when we look at the activity performed by Trusts only, the quality-adjusted 
index rises to 2.86%, mainly due to a large increase in Reference Costs activity.  
 
Similarly, we can also produce a Trusts-only input index. The low growth in inputs, as captured in our 
NHS input index, may not fully reflect the actual state of this growth: due to the reorganisation of 
the NHS and the discontinuation of PCTs, we might not be able to fully capture like-for-like inputs 
data.  Therefore, we also calculate the inputs growth for Trusts only, with the rationale being that 
their reporting may be less affected by the changes.  As shown in Table A2, the input index is much 
higher when taking only Trusts into account, with a mixed index suggesting growth of 2.27% and 
indirect index growth of 1.46%. 
 
Table A2: Input, output and productivity growth, Trusts only 
Years Output 
Growth 
 Input 
growth 
Productivity 
growth 
2013/14  ? 
2014/15 
2.86% 
Mixed 2.27% 0.58% 
Indirect 1.46% 1.39% 
 
Using this information we can produce Trust-only productivity growth figures, estimated as 0.58% 
for the mixed measure and at 1.39% for the indirect measure. 
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Appendix B 
B.1 Alternative sources of primary care data 
Introduction 
Although Primary Care spending amounts to around £9 billion a year
25
, there is a lack of 
comprehensive data coverage on even the most basic of activities.  Unlike secondary care, 
community care, rehabilitation and mental health services, there are no routinely collected 
comprehensive and available datasets from which activity information can be obtained.  This 
situation is unique in our productivity work, as it is the only output setting which requires us to rely 
on surveys or samples which may not be designed or well-suited to providing national-level 
summaries of aggregate activity. 
 
This appendix focuses on the issue of volume measurement in primary care in the absence of a 
single comprehensive good quality dataset, and is structured as follows: we discuss the availability of 
potential datasets, drawing a distinction between sample and survey sources; we then describe the 
main results from the main sources of data available and follow this with a discussion of the recent 
measures of primary care activity and compare them in a productivity framework.  We conclude 
with a discussion of the pros and cons of each method/source comparing sample and survey 
methods, the means of constructing national figures from the data and draw conclusions about 
future work. 
 
B.2 Measuring primary care growth 
We calculate primary care growth in the same way as for any type of NHS output.  This involves 
constructing a Laspeyres output index for primary care of the form: 
 ܺ௣௖ ൌ  ? ݔ௝௧ାଵܿ௝௧௃௝ୀଵ ? ݔ௝௧ܿ௝௧௃௝ୀଵ            (b1) 
 
Where ݔ௝captures the national annual volume of primary care activity of type j such as GP surgery 
consultations, practice nurse consultations, GP home visits, etc. and ܿ reflects the cost of each 
activity, with t indexing time.  The main practical challenge in England is to derive estimates of each 
type of ݔ௝.  Ideally there would be a comprehensive and exhaustive dataset, akin to Hospital Episode 
Statistics (HES) in the case of secondary care, which routinely captures all activity.  Although the data 
are already being captured by individual practice software management systems, there is no 
accessible single repository of these.  
 
In the absence of such data, there are broadly two sources of data that can be used: sample-based 
activity data from GP surgeries, and survey-based estimates from members of the population.  With 
both of these data sources, an additional step is required in extrapolating from the survey/sample 
results to an estimate of the national total: typically, this will involve multiplying a measure of the 
number or rate of consultations per person per year by an estimate of the population size. 
 
In what follows, we review various sample and survey data to determine the nature of their activity 
or response data and the extent to which they can be used to derive estimates of ݔ௝. 
 
                                                          
25
http://www.health.org.uk/sites/default/files/HealthFoundationSelectCommitteeSubmissionOnPublicExpenditureInTheN
HSAdditionalRequestsForEvidence.pdf 
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B.3 Sources of primary care activity data 
There are generally two types of primary care data sources available: sample data and survey data.  
The distinguishing feature of sample data is that the data are drawn from samples of GP practices, 
whereby all recorded activity undertaken by those practices is included in the sample data.  If the 
sample practices are representative of all practices, recorded activity can be simply scaled up to 
derive estimates of national-level activity.  If the practices are not representative, observed activity 
will need to be scaled up using appropriate sampling weights to correct for non-representativeness. 
 
The collection of survey data is aimed at achieving representativeness of the general population, but 
usually results in the under-representation of some groups, particularly the poorest members of 
society, either by design or through the process of data collection (Carr-Hill, 2013).  Surveys also rely 
on respondents recollecting events, and any form of self-reporting may bias estimates of health care 
utilisation (Sutton et al., 1999). 
 
There are additional problems in that the questions asked on surveys may not capture exactly what 
is required for the measurement of the volume of primary care activity.  We would like to know how 
many primary care consultations patients had over the course of the year.  But, for example, the 
survey which we currently use in calculating primary care activity (the GP Patient Satisfaction survey) 
asks when patients last saw their doctor or a practice nurse within defined discrete time periods.  
This necessitates some means of translating survey responses into a total volume of consultations.  
 
Sample based sources available for general research 
Examples of sample-based sources from which it might be possible to measure primary care activity 
include:  
 
x QResearch,  
x General Practice Research Database (GPRD), now Clinical Practice Research Datalink (CPRD) 
GOLD, 
x The Health Improvement Network (THIN) ,  
x ResearchOne, and  
x Somerset CCG data 
 
The first four datasets represent national collections of data, mainly from specific primary care 
computer systems from general practices which have made their data available for research.  All 
ĚĂƚĂƐĞƚƐƌĞƉƌĞƐĞŶƚĐŽŵƉůĞƚĞĞǆƚƌĂĐƚƐĨƌŽŵƚŚĞƉƌĂĐƚŝĐĞƐ ?ĐůŝŶŝĐĂůĐŽŵƉƵƚĞƌƐǇƐƚĞŵƐĂŶĚĐŽŶƚĂŝŶĚĂƚĂ
for each patient consultation.  Data include volumes and types of patient interactions with practice 
staff such as GP consultations, home visits and telephone consultations as well as practice nurse 
consultations.  As such, the data are sufficient to determine the volume of primary care activity in 
those practices providing the data.  If these are representative of all practices, the information may 
be used in productivity calculations.   
 
QResearch contains data from approximately 1,000 general practices from across the country using 
the Egton Medical Information Systems (EMIS) clinical computer system.  Although the earliest 
records are from the 1990s and the database is still ongoing, only summary data are publically 
available and only from 1995/96 to 2008/09 (Hippisley-Cox and Vinogradova, 2009).  It is these data 
that have formed the foundation for the estimation of volume of primary care activity for that 
period and, perhaps surprisingly, long beyond 2009. We shall return to this in due course. 
 
The CPRD database is currently owned by the Medicines & Healthcare Products Regulatory Agency 
(MHRA) and NHS National Institute for Health Research (NIHR), though the origins of the database 
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stem from 1987, and the database was developed as GPRD from Value Added Medical Products 
(VAMP) computer systems.  At present data are derived from around 690 practices covering 15 
million patients across the UK. 
 
THIN also has its roots in GPRD and after 2002 became a similarly structured alternative covering 
587 practices and over 12 million patients.  Due to both databases originating from GPRD, there is a 
substantial overlap in both practices and patients, with this amounting to 66% in the case of patient 
coverage (Carbonari et al., 2015). 
 
ResearchOne is a relatively new database produced by SystmOne software producers TPP in 
ĐŽŶũƵŶĐƚŝŽŶǁŝƚŚƚŚĞhŶŝǀĞƌƐŝƚǇŽĨ>ĞĞĚƐĂŶĚƚŚĞh<'ŽǀĞƌŶŵĞŶƚ ?ƐdĞĐŚŶŽůŽŐǇ^ƚƌĂƚĞŐǇŽĂƌĚ ? This 
dataset, while promising in terms of coverage, remains in an embryonic stage.  Access to it has been 
limited.  EĞǀĞƌƚŚĞůĞƐƐĂƌĞĐĞŶƚ<ŝŶŐ ?Ɛ&ƵŶĚƉƵďůŝĐĂƚŝŽŶĚĞƐĐƌŝďĞƚŚĞĚĂƚĂĂƐĐŽǀĞƌŝŶŐĂƌŽƵŶĚ ?
million patients and used an extract of 30 million individual contacts with patients in 177 practices 
between 2010/11 and 2014/15 (Baird et al., 2016). 
 
An issue with CPRD, THIN and ResearchOne is the lack of publicly available information on the 
practices that participate in either database.  Practices may join or withdraw over time so coverage 
and, hence, representativeness varies year-by-year.  If there is an unknown degree of variation in 
coverage over time, it will be impossible to determine whether changes in observed consultations 
are functions of changing coverage or changes in volume of consultations.  As an example of the 
extent of this potential issue, although the headline figures for CPRD states that more than 500 
ƉƌĂĐƚŝĐĞƐĂƌĞƉĂƌƚŝĐŝƉĂƚŝŶŐ ?ƚŚĞƌĞĂƉƉĞĂƌƐƚŽďĞŽŶůǇ ? ? ?ƉƌĂĐƚŝĐĞƐƚŚĂƚĂƌĞ ‘ĂĐƚŝǀĞůǇ ?ƉĂƌƚŝĐŝƉĂƚŝŶŐ
(Hobbs et al., 2016). 
 
The Somerset Symphony data are available from an unrelated CHE project, which addressed the 
impact of greater collaboration between primary, community, mental health, acute and social care, 
particularly for people with complex conditions (Kasteridis et al., 2015).  These data contain 
summarised data on GP activity for the whole population of Somerset 2012/13 to 2013/14.  This 
dataset has been made available for the purposes of comparison and we are grateful to Somerset 
CCG for their permission to use the data. It is likely that other CCGs also collect similar data. 
 
Coverage and representativeness of sample datasets 
Ideally, sample-based databases would contain data from randomly selected practices or practices 
that are representative of the broader population of practices and patients.  Unfortunately selection 
into these data sets is not random, appearing to be mostly driven by the type of software used by 
each practice (e.g. EMIS for QResearch).  Representativeness of the data is rarely explored in any 
detail by the data providers, with the exception of QResearch which has made an explicit attempt to 
assess the representativeness of the data sample and apply a set of weights to estimate a national 
figure (Hippisley-Cox and Vinogradova, 2009).   
 
While CPRD GOLD is often commonly cited as being a broadly representative sample, the sole source 
of publicly available information regarding its representativeness comes from a published 
conference abstract (Campbell et al., 2013), which states: 
 
There were 4.6 million patients on Census Day in GOLD, 7.3% of the UK 
population with little variation by gender but a lower representation of younger 
age patients. Crude death rates were nearly identical to national rates (8.70 per 
1,000 vs. 8.69 in GOLD). ASMR in GOLD were lower than national rates by 11% in 
men (582.8 per 100,000) and 8.6% in women (426.9 per 100,000), with only 
slight variation by country. Age-ƐƉĞĐŝĨŝĐDZ ?ƐĂŵŽŶŐƚŚĞ'K>ƉŽƉƵůĂƚŝŽŶ
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ranged from 3% to 25% below those reported for the UK population except 
ĂŵŽŶŐĐŚŝůĚƌĞŶч ? ?ǇĞĂƌƐǁŚĞƌĞDZ ?ƐǁĞƌĞŵŽƌĞƚŚĂŶ ? ?йůŽǁĞƌ ?dŚĞŵĞĚŝĂŶ
list size was higher in GOLD practices (England 8,355 pts., Scotland 5,998 pts.) 
than for all England (5,918 pts.) and all Scotland (4,943 pts). 
 
Far from confirming that CPRD is broadly representative, the figures suggest that the sample differs 
from the general population in several important respects. 
 
It is difficult to correct for non-representativeness even with regression-based modelling to derive 
sampling weights.  This is because the weights are based on observable characteristics such as 
practice list size and composition, or geographical location. But participation may be based on 
unobserved factors, such as the inclination of practice staff to engage in research or continued 
professional development, and these factors may also influence the volume and distribution of 
activity.  If so, then the measured activity of an included practice may not be reflective of the activity 
of other practices, even though they may look similar on the basis of observed characteristics. In 
such cases, sampling weights based on regression models will still produce biased estimates of 
national activity, with the nature of this bias being unknown. 
 
A further issue with many of these datasets is the evolving and fluctuating nature of the coverage of 
the data, with new practices joining and old practices dropping out.  This makes it difficult to 
measure the proportion of coverage.  Without a clear idea of the coverage, it is difficult to produce 
national estimates of activity.  It is perhaps not surprising that Kontopantelis et al conclude that 
 ‘Researchers need to be cautious when generalising findings from samples of providers using a single 
computing system ?(Kontopantelis et al., 2013). 
 
Possibly due to the more rigorous attempts to assess consistency over time and representativeness 
of the sample, the QResearch database has been the most popular sample-based means for deriving 
national estimates of both the volume and composition of primary care use.  Indeed QResearch was 
used as the source of estimates of primary care activity in national productivity calculations until 
2009, the point at which QResearch became publicly unavailable.  Even now, despite the lack of 
contemporary data, QResearch remains the prime data source for many of the current estimates of 
primary care activity.  These include those produced by ONS and the Deloitte estimates of 370m 
consultations per year (Deloitte, 2014), which were reported by Maureen Baker, Chair of the Royal 
College of GPs at the 2016 Special Local Medical Committees (LMC) Conference.
26
 
 
Survey based measures of primary care service use data 
Many national surveys ask people about their contacts with primary care providers.  The form of the 
question varies across surveys and over time.  These questions can be used to provide insight into 
the frequency and type of contact with primary care, provided that some relationship can be posited 
between the survey response ݎ and the amount of primary care activity ݔ෤௝ provided to those 
questioned, such that ݔ෤௝ ൌ ݂ሺݎሻ.  Survey data also tend to need to be scaled to derive estimates of 
national levels of the different types of activity, such that ݔ෤௝ߜ௝ ൌ ݔ௝. 
 
In what follows, we review various survey data to determine the nature of their activity or response 
data and the extent to which they can be used to derive estimates of ݔ௝. 
 
 
 
                                                          
26
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There are a number of large scale surveys which may potentially contain data on primary care 
activity.  We have identified the following: 
 
x GP Patient Survey 
x British Household Panel Survey (now part of Understanding Society) 
x Health Survey for England 
x General Lifestyle Survey (formerly General Household Survey) 
 
In general, the surveys are designed such that they aspire to be representative of the general 
population.  They do however introduce a few other problems, the main ones being that they 
capture reported rather than actual behaviour, that the questions used may not completely capture 
the information required for productivity calculations, that there may be inconsistency over time in 
how questions are asked, and that the aspiration of representativeness may not be realised.  
 
The GP Patient Survey is a twice-annual questionnaire sent to approximately 1.32 million adults 
registered with a GP in England.  The aggregate results represent the current source of data for our 
productivity measure.  The questionnaire asks a simple question about when a respondent last saw 
or spoke to a GP from their surgery.  Responses are categorised in ordered temporal categories: in 
the past 3 months; between 3 and 6 months; between 6 and 12 months; more than 12 months; 
never.  An additional question asks whether a nurse had been spoken to.  GP Patient Survey data are 
available since 2007.  However, the questionnaire underwent a major restructuring after the June 
2011 publication, including a revised weighting scheme, in order to better adjust for socio-economic 
characteristics of the sample.  Survey documentation states that post-June 2011 results should not 
be compared with pre-June 2011 results. 
 
The British Household Panel Survey (BHPS) was a multi-purpose survey with a unique approach in 
following the same representative sample of individuals over a period of years.  The survey began in 
1991 and ran to 2008 (wave 18), and consisted of approximately 8,000 households.  From 2010 
ŽŶǁĂƌĚƐƚŚĞƐƵƌǀĞǇǁĂƐŝŶĐŽƌƉŽƌĂƚĞĚŝŶƚŽƚŚĞ ‘hŶĚĞƌƐƚĂŶĚŝŶŐ^ŽĐŝĞƚǇ P The UK Household 
>ŽŶŐŝƚƵĚŝŶĂů^ƚƵĚǇ ?ǁŚŝĐŚŶŽǁĨĞĂƚƵƌĞƐĂƉƉƌŽximately 40,000 households including most of those 
remaining in the last BHPS wave.  The Understanding Society study has been running since 2009 
(wave 1) and data are available up to and including Wave 5 (2014).  Questions on health service use 
were initially dropped during the incorporation of the BHPS into the Understanding Society study.  
However, wave 7, which started in Q1 2015, featured a new question regarding visits to the GP 
within the last 12 months.  Responses are in ordered categories: none; one to two; three to five; six 
to ten; and more than ten.  Given the recent introduction of this question, the earliest that this could 
be incorporated into productivity calculations would be for the 2015/16-2016/17 measure. 
 
The Health Survey for England (HSE) for 2013 contains data on the use of health services, including 
GPs.  Specific questions include how many times a patient talked to their GP in the past 2 weeks, the 
number of contacts, and where the contact took place.  It also has additional questions regarding 
how many times a patient talked to a GP within the last year.  The questions do not appear to be 
consistent over time (and they do not appear at all in HSE 2012) but going forward they may 
represent an alternative data source. 
 
The General Lifestyle Survey (formally General Household Survey) ran from 1971 to 2011.  Data 
about the type and volume of GP consultations was collected from 1971-1996, in 1998 and from 
2000-2011.  The latest versions of the survey ask about the number of contacts with a doctor and 
with a nurse practitioner during the previous two weeks.  Further questions also ask about location 
(telephone; home; surgery; health centre; other). 
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Our conclusion is that some survey data appear to be improving over time in their suitability for the 
purposes of calculating productivity.  It may be possible that, for the 2015/16-2016/17 measure, the 
Health Survey for England contains questions which are more suited to productivity measurement.  
At the very least, it will provide an alternative source for comparison and triangulation. 
 
B.4 Key findings from the main data sources 
In this section we detail the main findings from the three key sources of data that are available, have 
been used or show potential for use in calculating primary care activity and growth figures.  They 
are: 
 
x QResearch 1995/96 to 2008/09;  
x GP patient survey 2011  W 2016 (ongoing); and  
x Somerset Symphony Project data 2012/13  W 2013/14 (ongoing). 
 
QResearch 
The final QResearch report available (Hippisley-Cox and Vinogradova, 2009), represents a major data 
source in understanding primary care activity but the fact it was last reported for 2008/09 
represents a limitation for any current estimates.  Some current estimates of primary care activity 
are simple extrapolations of the trends over the observed period of fourteen years for which 
QResearch data were available to more recent years, but these estimates fail to take advantage of 
contemporary data. 
 
The key data from QResearch are: the average number of consultations per person-year over time; 
the distribution of consultation rates across the population; proportion of consultations by staff type 
and by location.  All graphs are taken from the original QResearch report. 
 
 
Figure B1: QResearch consultation rates per person-year, 1995/96  ? 2008/09 
 
Figure B1 shows the average crude consultation rates over time and shows, especially from 
1999/2000 onwards, a fairly linear trend of increase over time.  The rates range from an average of 
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3.91 consultations per person per year in 1995/96 to 5.53 consultations per person per year in 
2008/09.  
 
QResearch also reports estimates of total consultations in England.  This is a function of both 
consultation rates and total population and is shown in Table B1.  Population weights were 
determined by use of a linear regression model to correct for the QResearch sample not being a 
random sample of all practices or the general population.  Weights included age-sex standardisation, 
practice size, mortality rates and Townsend deprivation scores.  The table also shows the 95% 
confidence interval for total consultations, the variation driven by the sampling uncertainty 
surrounding the estimates of the consultation rates. 
 
Table B1: QResearch estimates of consultation rates and volume for England (000s) 
Financial 
year 
Adjusted mean of 
consultation rates 
Total registered 
population 
Estimated number of 
consultations in England 
95% CI for 
consultations 
1995/96 4.45 50,400 224,500 205,900 243,100 
1996/97 4.39 50,600 222,000 203,700 240,400 
1997/98 4.34 50,900 220,700 204,700 236,800 
1998/99 4.30 51,100 219,900 205,400 234,500 
1999/2000 4.30 50,900 218,900 205,600 232,300 
2000/01 4.39 51,300 225,300 212,300 238,300 
2001/02 4.66 51,300 239,000 226,700 251,300 
2002/03 4.78 51,500 246,200 235,500 257,000 
2003/04 4.92 52,700 259,400 249,500 269,300 
2004/05 5.04 52,500 264,900 255,300 274,500 
2005/06 5.30 53,400 283,200 274,300 292,000 
2006/07 5.41 53,900 291,500 282,500 300,600 
2007/08 5.41 53,900 291,900 282,800 301,100 
2008/09 5.64 53,900 303,900 294,200 313,600 
 
Table B1 shows a number of interesting features of the data.  Firstly, the total increase in 
consultations from 1995/96 to 2008/09 (35.4%) has largely been driven by increases in consultation 
rates (21.6%) rather than increases in population size (6.9%).  The second feature is the relatively 
wide 95% confidence intervals, implying substantial uncertainty surrounding the estimated 
consultation rates despite the huge sample size.  Statistical tests show that, in these in 13 years of 
paired growth measures, only one year (2004/05 to 2005/06) exhibits a growth in consultations 
statistically significant from zero. 
 
Calculation of productivity figures requires a distinction to be made between the types of 
consultations, principally the member of staff that undertakes the consultation and the location of 
the consultation.  Costs differ across these categories, so changes to the distribution of the 
consultations may have an important impact on estimates of the volume of primary care activity.   
 
Table B2 shows the 2008/09 breakdown of consultation types and locations as used to define 
distinct primary care activities in the CHE productivity measure. 
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Table B2: 2008/09 Q-Research distribution of consultation types 
 GP home 
visit 
GP 
telephone 
GP 
surgery 
GP 
other 
Practice 
nurse 
Other 
clinicians 
All consultations 2.00% 6.23% 52.86% 1.83% 33.49% 3.60% 
Just GP 
consultations 
3.17% 9.89% 84.02% 2.91%   
 
Figure B32 shows the declining proportion of consultations taken by GPs relative to those taken by 
practice nurses, with rates for GPs having steadily fallen from 75% in 1995/96 to 62% by 2008/09.  
Figure B3 shows declining rates for combined GP surgery consultations and home visits, and a 
significant increase in telephone consultations.  The volume of telephone consultations has risen 
every year since 1995/96. 
 
 
Figure B2: Percentage of consultations by clinician 
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Figure B3: Percentage of consultations by location 
 
GP Patient Survey 
The GP Patient Survey gives percentages of patients who report having contact with their GP or 
primary care nurse within time-frames of 3, 6, 12 months and beyond 12 months (and by default, 
never).  Although these data are clearly related to the actual number of GP and nurse consultations 
they are not entirely equivalent.   
 
Table B3: GP appointment 
Report date Financial year Within 3 months 3-6 months 6-12 months 12 months + 
2012-Jun 2011/12 54.00% 17.62% 13.77% 13.25% 
2013-Jun 2012/13 54.83% 17.52% 13.52% 12.82% 
2014-Jul 2013/14 54.28% 17.57% 13.79% 13.04% 
2015-Jul 2014/15 53.38% 17.63% 14.05% 13.54% 
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Figure B4: Last spoke to or saw a GP 
 
Table B4: Practice nurse consultations 
Report date Financial year Within 3 months 3-6 months 6-12 months 12 months + 
2012-Jun 2011/12 35.05% 16.93% 16.22% 24.11% 
2013-Jun 2012/13 35.80% 16.97% 16.21% 23.66% 
2014-Jul 2013/14 35.91% 17.01% 16.23% 23.61% 
2015-Jul 2014/15 35.86% 17.92% 16.89% 22.12% 
 
 
Figure B5: Last spoke to or saw a nurse 
 
The GP Patient Survey suggests that fewer people are seeing GPs within 3 months and more are not 
seeing their GP in the previous year or, indeed, ever (as shown in Table B3 and Figure B4).  There has 
been an increase in the proportion seeing a practice nurse within 3 months, and a decrease in the 
proportion never seeing them (as shown in Table B4 and Figure B5).  The proportions in each time 
frame are erratic from year to year.  
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Although the years of the GP Patient Survey do not overlap the QResearch timeframe and so a like-
for-like comparison is not possible, the lack of a systematic growth in the numbers of the population 
seeing their GP within 3 months suggests that the growth in rates observed up to 2009 has not 
continued. 
 
Somerset Symphony Project data 
^ŽŵĞƌƐĞƚ ?Ɛ^ǇŵƉŚŽŶǇWƌŽũĞĐƚŝƐĚĞƐŝŐŶĞĚƚŽĞƐƚĂďůŝƐŚŐƌĞĂƚĞƌĐŽůůĂďŽƌĂƚŝŽŶďĞƚǁĞĞŶƉƌŝŵĂƌǇ ?
community, mental health, acute and social care, particularly for people with complex conditions 
(Kasteridis et al., 2015).  For the purpose of the project, a large dataset was created which links 
acute, primary care, community, mental health and social care data for each individual in the 
Somerset population.  The data are derived from various primary sources, all of which cover twelve 
months and are compiled into two annual datasets.  The datasets contain anonymised individual-
level data about what care has been received and at what cost across all care settings.  Using these 
data for measuring primary care activity gives us an alternative data source which is comprehensive 
and of high quality.  However, the sample is limited to those living in Somerset and so may not be 
representative of the whole of England.  
 
The Somerset Symphony Project database contains data for every occasion a patient interacted with 
the GP Practice, either through a physical visit (either with a GP or other health professional) or an 
ĞǀĞŶƚƌĞĐŽƌĚĞĚŝŶƚŚĞƉĂƚŝĞŶƚ ?ƐŵĞĚŝĐĂůƌĞĐŽƌĚ ‘ŝŶĂďƐĞŶƚŝĂ ? ?ƐƵĐŚĂƐĂƚĞůĞƉŚŽŶĞĐŽŶƐƵůƚĂƚŝŽŶ ? The 
data capture patient interactions within their general practice including face-to-face contacts and 
telephone consultations.  These data are summarised in Table B5. 
 
Table B5: Somerset GP practice interactions 
General practice 
consultations within year, 
C 
2012/13 2013/14 
 Nr % Nr % 
0 149,267 26.1 165,778 28.68 
1 80,067 14 78,867 13.65 
2 61,580 10.77 60,152 10.41 
3 48,996 8.57 47,308 8.19 
4 39,485 6.9 38,073 6.59 
5 31,818 5.56 30,778 5.33 
6 26,145 4.57 24,906 4.31 
7 21,124 3.69 20,605 3.56 
8 17,426 3.05 16,684 2.89 
9 14,563 2.55 13,600 2.35 
10 12,050 2.11 11,579 2 
>10 69,467 12.14 69,652 12.05 
Total Population (N) 571,988 100 577,982 100 
Total Activity, C × N 2,640,635 -- 2,604,078 -- 
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We can observe the total number of interactions by multiplying the number of people in different 
activity levels with the actual activity (e.g. 61,580 multiplied by 2, as this many people had 2 
interactions).  The total numbers of interactions in 2012/13 and 2013/14 were 2,640,635 and 
2,604,078 respectively, a fall of -1.38% despite a 1.05% increase in population.  Average interactions 
per member of the population fell from 4.62 to 4.51, and the standard deviations of consultations 
are 6.6 and 6.7 respectively.  The mean is considerably lower than the rate of around 5.6 interactions 
per person suggested by QResearch (for 2008/9) 
 
Of note is the high proportion (approximately 28%) of the population who had no interactions with 
the practice and the relatively high numbers (approximately 12%) who had over 10 interactions with 
the practice.  These data show substantial heterogeneity in rates across the population. 
 
It is possible to cross-reference these data with that in the GP Patient Survey, which is also reported 
at CCG level.  Table B6 summarises the activity from the GP Patient Survey for the Somerset CCG. 
 
Table B6: Somerset CCG GPPS survey results 
Report Date within 3 months 3-6 months 6-12 months 12 months + never 
12/13 54.28% 16.88% 13.79% 13.49% 0.94% 
13/14 51.59% 18.39% 14.09% 14.58% 1.26% 
 
When we compare the activity reported in the survey to the activity levels from the Somerset 
Symphony Project data, we observe marked differences, especially for the number of individuals 
who have not seen the GP in the past year.  The survey data suggests that 14.4% (ie 13.49%+0.94%) 
and 15.8% of people in Somerset CCG had no GP appointments in 2012/13 and 2013/14 
respectively.  In contrast, the Somerset Symphony Project data suggest that 26.1% in 2012/13 and 
28.7% in 2013/14 of individuals had no interactions with primary care.   
 
While the Somerset Symphony Project dataset is a complete count of activity, the survey data relies 
on a small subsample.  Nationally, from 19,941 surveys that were sent out in 2013/14 (20,819 in 
2012/13), less than half (9,909, 48%) were returned (8,948, 45% in 2012/13).   
 
These much lower estimates of primary care usage call into question the reliability of using survey 
data. 
 
B.5 Current and proposed methods of measuring primary care activity 
This section details various measures of primary care activity which can be used to compare the 
estimates of activity growth from each measure. 
 
Extrapolations based on QResearch data 
The RCGP recently claimed that  ‘'WƐĂƌĞĐŽŶĚƵĐƚŝŶŐĂƚůĞĂƐƚ ? ? ?ŵƉĂƚŝĞŶƚĐŽŶƐƵůƚĂƚŝŽŶƐĞǀĞƌǇǇĞĂƌ ? 
60m more than five years ago ? ?27  Both of these figures were taken from a 2014 Deloitte report, 
originally designed to estimate a presumeĚ “ĨƵŶĚŝŶŐŐĂƉ ?ŝŶŐĞŶĞƌĂůƉƌĂĐƚŝĐĞ ?ďƵƚĨƌŽŵǁŚŝĐŚŵŽƐƚ
claims regarding primary care consultation counts have subsequently been drawn (Deloitte, 2014).  
For example, ƚŚĞE,^ŶŐůĂŶĚŶŶƵĂůĐĐŽƵŶƚƐĨŽƌ ? ? ? ? ? ? ?ƐƚĂƚĞƐƚŚĂƚ “ĂƌŽƵŶĚ ? ? ?ŵŝůůŝŽŶ'W
ĐŽŶƐƵůƚĂƚŝŽŶƐƚŽŽŬƉůĂĐĞ ?.28  tŚŝůĞŶŽŵĞƚŚŽĚŽƌƌĞĨĞƌĞŶĐĞŝƐƉƌŽǀŝĚĞĚĨŽƌƚŚŝƐĨŝŐƵƌĞ ?E,^ŶŐůĂŶĚ ?Ɛ
                                                          
27
 http://www.rcgp.org.uk/news/2015/november/poll-results-show-general-practice-struggling-to-cope-with-tsunami-of-
increased-patient-demand.aspx 
28
 https://www.england.nhs.uk/wp-content/uploads/2015/07/nhse-annual-report-2014-15.pdf  
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ǁĞďƐŝƚĞƉƌŽǀŝĚĞƐƉƌĞƐĞŶƚĂƚŝŽŶƐůŝĚĞƐĞŶƚŝƚůĞĚ “Improving General Practice  W ĂĐĂůůƚŽĂĐƚŝŽŶ ?which 
state this estimate for 2013/14.
29
  ƐǁŝƚŚĞůŽŝƚƚĞ ?ƐĨŝŐƵƌĞƐ ?ƚŚŝƐĂƉƉĞĂƌƐƚŽďĞďĂƐĞĚŽŶĂstraight 
line extrapolation from QResearch data collected between 1995 and 2008, without population 
adjustment.  This figure was also cited in the Keogh Report as an estimate for 2012/13
30
, with the 
same source cited. 
 
The Deloitte report is somewhat opaque on the method adopted to extrapolate figures, stating: 
 
 ?dŚĞůŝŶĞĂƌƚƌĞŶĚŝŶƚŚĞĐŽŶƐƵůƚĂƚŝŽŶƌĂƚĞďĞƚǁĞĞŶ ? ? ? ?ĂŶĚ ? ? ? ?ŚĂƐďĞĞn used to 
forecast consultation rates for each age band until 2018.  These forecast consultation 
rates are applied to forecast population estimates (ONS) in order to estimate the total 
ŶƵŵďĞƌŽĨĐŽŶƐƵůƚĂƚŝŽŶƐ ? ?
 
Table B7 reports the estimates of consultations from the last observed figure (2008/09) to the 
2017/18 estimates.  While few details are provided about the method adopted, we are able to 
replicate these results.  It appears that the estimates in the Deloitte report are constructed from 
observed population figures for England, grouped into five-year age bands.  Estimates of population 
growth rates for each of these five-year age bands are constructed from an extrapolated linear trend 
growth by age band between 1995/96 and 2008/09.  dŚĞƉŽŝŶƚĞƐƚŝŵĂƚĞĨŽƌ ? ? ? ? ? ? ?YZĞƐĞĂƌĐŚ ?Ɛ
consultation count for each age band is scaled up by the implied growth rate on the basis of the 
estimated population growth. 
 
Table B7: Deloitte estimates of general practice consultations 
Year Consultations (000s) 
2008/09 303,900 
2009/10 314,585 
2010/11 327,159 
2011/12 338,435 
2012/13 349,319 
2013/14 360,838 
2014/15 372,471 
2015/16 384,303 
2016/17 396,656 
2017/18 409,306 
 
There is ample reason to treat with caution the accuracy of estimates derived using this method.  All 
predicted consultation figures (from 2009/10 onwards) are built on applying an observed historical 
trend growth to a single survey-based estimated figure: the 2008/09 QResearch point estimate of 
303.9m consultations.  Note that even this figure is uncertain; there being a 95% confidence interval 
of 294.2m to 313.6m.   
 
Furthermore, it is important to distinguish between consultations in general practice, and 
consultations carried out by general practitioners.  There may have been changes in the composition 
of consultations according to staff type.  The QResearch survey figures aggregate all types of 
consultations: from 1995/6 to 2008/9, consultation rates rose from 2.95 to 3.44 per person per year 
                                                          
29
 https://www.england.nhs.uk/wp-content/uploads/2013/09/igp-cta-evid.pdf  
30
 http://www.nhs.uk/NHSEngland/keogh-review/Documents/UECR.Ph1Report.Appendix%201.EvBase.FV.pdf 
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(pppy) for GPs, and from 0.84 to 1.90 pppy for nurses.  In 1995/96 GP surgery consultations made up 
76% of all consultations and nurse consultations 22%; by 2008/9 these proportions were 62% and 
34% respectively.  Breaking down the Deloitte estimates, by including a linear extrapolation of the 
changing make-up of consultations in general practice, implies the following estimates for general 
practice consultations carried out by GPs, nurses, and others (Table B8). 
 
Table B8: Deloitte volume of consultations by type 
Year 
Total consultations  
(000s) [Deloitte] 
GP consultations 
(000s) 
Nurse 
consultations 
(000s) 
Other 
consultations 
(000s) 
2008/09 [survey] 303,900 189,050 104,197 10,653 
2009/10 314,585 193,954 109,810 10,822 
2010/11 327,159 199,997 116,110 11,052 
2011/12 338,435 205,220 121,978 11,236 
2012/13 349,319 210,191 127,723 11,405 
2013/14 360,838 215,527 133,718 11,593 
 
Such an adjustment points to a large estimated growth in consultations carried out by nurses (28%, 
or 29.5m) between 2008/09 and 2013/14.  The estimated rise in the number of GP consultations is 
smaller than this, both proportionately (14%) and even as a raw count (26.5m). 
 
CPRD-based analyses 
Two publications have been found which use CPRD data to analyse primary care workload  W a 
Nuffield Trust blog estimating the number of consultations for each financial year between 2010/11 
and 2013/14 (Curry, 2015) and a Lancet publication which estimates the number of consultations 
over a longer period, between 2007/08 and 2013/14 (Hobbs et al., 2016). 
 
The key objective of the Nuffield blog was to challenge the simple extrapolation assumption that 
underpins both the Deloitte and NHS England estimates of primary care activity.  They analysed 
CPRD data from 3.2 million patients from 337 practices in England between 2010/11 and 2013/14  W 
ƚŚŝƐǁŽƵůĚĂƉƉĞĂƌƚŽĐŽǀĞƌƚŚĞ ‘ĂĐƚŝǀĞ ?ƉĂƌƚŝĐŝƉĂŶƚƐŝŶWZĂƚ ƚŚŝƐƚŝŵĞ ? They report the number of 
consultation types per patient per year as shown in Table B9. 
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Table B9: Nuffield Trust and Hobbs et al estimates of consultations per person 
Year Curry (2015) Hobbs et al. (2016) 
 
Total GP 
Total 
Nurse 
Total 
Nurse & 
GP 
Total 
other 
Total 
(All) 
Total GP 
Total 
Nurse 
Total 
Nurse & 
GP 
2007/08      3.35 1.32 4.67 
2008/09      3.43 1.35 4.78 
2009/10      3.52 1.39 4.91 
2010/11 3.43 0.98 4.41 3.16 7.57 3.57 1.37 4.94 
2011/12 3.49 1.02 4.51 3.44 7.95 3.64 1.37 5.01 
2012/13 3.55 1.05 4.6 3.61 8.21 3.76 1.38 5.14 
2013/14 3.49 1.06 4.55 3.74 8.29 3.8 1.36 5.16 
 
Curry finds that the number of consultations per person has risen in line with those produced by 
extrapolating ƚŚĞYZĞƐĞĂƌĐŚĚĂƚĂ ?ďƵƚŽŶůǇǁŚĞŶƚŚĞ ‘ŽƚŚĞƌƐ ?ĐĂƚĞŐŽƌǇŝƐŝŶĐůƵĚĞĚ ? As such, one of 
the key conclusions drawn is that the growth in consultations has largely been driven by non-GP 
ƉƌĂĐƚŝƚŝŽŶĞƌƐ PǁŚĞƌĞĂƐ'WĐŽŶƐƵůƚĂƚŝŽŶƐƌŽƐĞďǇĂƌŽƵŶĚ ? ? ?A?ƉĞƌĂŶŶƵŵ ? ‘ŽƚŚĞƌ ?ƉƌĂĐƚŝĐĞƐƚĂĨĨ
(including pharmacists, physiotherapists, speech therapists, etc.) has risen by 5.8% per annum and 
now represents the largest component of primary care activity.  In total all practice consultations 
rose on average by approximately 3% per annum. 
 
If we limit the consultation rate to just those undertaken by nurses and GPs we find a much smaller 
growth rate over the period of just 1.1% per annum. In fact, there was a fall of 1.7% (from 4.6% to 
4.55%) between 2012/13 and 2013/14.  The author also raises concerns regarding the 
representativeness of the sample and cites potential coding discrepancies and a lack of clarity over 
how some patient contacts are recorded across practices. 
 
Hobbs et al. adopt a similar approach using a cut of CPRD data that overlaps that of the Nuffield 
Trust analysis, for the years from 2007/08 to 2013/14.  Their data cover 398 practices, of which 360 
contributed to the first four years of the analysis, with this figure declining to 316 in the final year.  
They find that the contributing practices tended to be large with mean practice sizes in excess of 
9,000 patients, mostly from the South of England and over-representative of those achieving high 
QOF scores.  Hobbs et al. ĂůƐŽĞǆĐůƵĚĞĚƚŚĞĐŽŶƚƌŝďƵƚŝŽŶŽĨ ‘ŽƚŚĞƌ ?Ɖractice staff from their 
calculations.   
 
Hobbs et al. report average per annum growth rates of 2.1% and 0.51%, respectively for GPs and 
nurses over the whole time period, and an average annual total growth in activity rates of 1.7%.  In 
terms of GP consultation type makeup, an average 87% over the whole time period consists of face-
to-face visits at the surgery, an average 10.5% of telephone consultations and an average of 2.4% of 
home visits.  There is a noticeable increase from 8.1% to 14.2% in the share of telephone 
consultations over the period, while the share of face-to-face consultations decreased from 89.3% to 
83.7%.   
 
In addition to the rates and types of consultations, Hobbs et al. also looked at the duration of 
consultations, which has risen from an average of 8.45 minutes in 2007/08 to 8.86 minutes in 
2013/14.  
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It is informative to compare rates of consultations for GPs and nurses across studies over the same 
time period 2010/11 to 2013/14 from these two analyses.  Given what would appear to be a 
substantial overlap in the data used, we would expect very similar results.  However, there are fairly 
substantial differences in calculated rates.  In general, Hobbs et al. calculate total rates that are 
approximately 0.55 per person per year above those reported by Curry.  Moreover, that overall 
difference masks two diverging trends between GPs and nurses.  For GPs, Hobbs et al. calculate an 
average per annum increase of over 2%, whilst Curry calculates a rate closer to 0.6%.  For nurses, 
Hobbs et al. calculate an average annual growth rate of -0.24%, whereas Curry calculates a growth 
rate of 2.7%.  
 
The degree of difference between the two analyses, despite using the same data, is substantial and 
raises issues about the conclusions that can be drawn from using the CPRD data.  Although practice 
coverage may not be completely comparable across the two analyses, it seems unlikely that this 
could be the cause of such differences.  The differences may be due to sampling variation, but it 
raises the question of how reliable a sample-based method from a non-representative sample of 
practices may be if sampling variation is so high. 
 
Comparison of approaches in calculating volumes 
The data available permit comparison of results across alternative measures.  In order to calculate 
raw number of consultations, we used the estimates of the average number of consultations and 
applied them to the ONS population estimates.  To construct the number of consultations, we 
assumed the starting year (2008/9) is the same as the figure provided by Deloitte and is based on 
the QResearch data (Hippisley-Cox and Vinogradova, 2009).  
 
All measures follow the same basic framework: an estimate of consultation rates per population in a 
specific year is applied to population estimates in that year.  Growth in the volume of consultations 
may therefore be a function of rate growth and/or population growth. 
 
The Deloitte measure extrapolates an observed two-year linear trend between 2008 and 2009 up to 
2013/14, accounting for changes in age and gender (Deloitte, 2014).  This growth in consultation 
rates is applied to contemporary measures of population growth available from the ONS.  Rather 
than extrapolate a trend last observed in 2009, the CHE approach uses contemporary survey data to 
estimate changes in the rate of consultations as measured by changes in the probability of seeing a 
GP within the past 3 months (Bojke et al., 2016a).  These measures of changes in rates are then 
applied to the same population growth estimates as the Deloitte approach.  The Deloitte approach 
applies the changes and rates over time to a fixed anchor point of the last point estimate from the 
QResearch. 
 
Neither Hobbs et al. nor Curry, the two CPRD based studies, directly estimate volumes of 
consultations (Hobbs et al.2016, Curry, 2015).  Nevertheless, by applying the published estimated 
rates of the CPRD consultations per population or age/gender categorised population to the ONS 
population estimates, we are able to obtain measures of volume in an analogous manner to that of 
Deloitte.  As the source data for each study contains considerable overlap, then we would expect a 
high level of agreement between these two estimates, indeed they should not be considered as 
independent in the way perhaps the CHE and Deloitte estimates are.  As the Curry study provided 
just overall population consultation rates, some differences may occur due to the more aggregate 
nature of population growth measures. 
 
The calculation of national volumes of consultations from the Somerset data (Kasteridis et al., 2015) 
is constructed by applying the observed average (yearly) rate of primary care appointments to the 
entire population. 
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The ONS reports estimates of growth rates, which also used QResearch data up until the point that 
the data were no longer made publically available, are included for purposes of comparison (Office 
for National Statistics, 2015). 
 
Table B10: Comparison of numbers of consultation: GP and Nurse consultation total (000s); incl. setting 
 “KƚŚĞƌ ? 
Method / 
Data 
CHE Deloitte ONS-existing Curry 2015 Hobbs et 
al 2016 
CHE 
Somerset 
data 
 Survey 
(3 months) 
Extrapolation Extrapolation CPRD Somerset 
CCG data 
2008/09 303,900 303,900 303,900  244,567  
2009/10 310,795 314,585 308,155  253,486  
2010/11 301,197 327,159 315,550 398,503 257,044  
2011/12 315,127 338,435 323,439 422,202 262,855  
2012/13 326,863 349,319 328,938 439,184 272,051 246,959 
2013/14 326,957 360,838 n/a 446,548 275,750 242,691 
 
Table B10 shows considerable variation in measures of volume of activity. In part this is due to the 
inclusion / ĞǆĐůƵƐŝŽŶŽĨƚŚĞ ‘ŽƚŚĞƌ ?ĐĂƚĞŐŽƌǇĂŶĚƚŚĞĚĞĨŝŶŝƚŝŽŶŽĨ ‘ŽƚŚĞƌ ?ĂĐƌŽƐƐƐŽƵƌĐĞƐ.  For 
example, QResearch includes other clinicians such as pharmacists, medical students, dieticians and 
social workers.  Administrative staff are not included.  The definition of other activity in the CPRD 
ƵƐĞĚďǇƵƌƌǇŝƐƐŝŵƉůǇ ‘ŽƚŚĞƌƐƚĂĨĨ ? ?ǁŚŝĐŚŵĂǇ or may not include administrative staff.  As 
QResearch indicates a relatively small contribution of around 3.5% of activity by other clinical staff 
and Curry finds a contribution of around 45%, it is unlikely that they measure the same type of 
activity.   
 
For this reason, we also construct a table using more comparable data which excludes the setting 
 ‘ŽƚŚĞƌ ?ĂŶĚŝƐƐŚŽǁŶTable B11 below.  The Hobbs et al. figures are as they were in Table B1 and the 
, ?ĞůŽŝƚƚĞĂŶĚKE^ĨŝŐƵƌĞƐƌĞŵŽǀĞƚŚĞĂƐƐƵŵĞĚ ? ? ?A?ŽĨĂĐƚŝǀŝƚǇƚŚĂƚŝƐĐůĂƐƐŝĨŝĞĚĂƐ ‘ŽƚŚĞƌ ? ? We 
ŚĂǀĞĂůƐŽĂƐƐƵŵĞĚƚŚŝƐĨŝŐƵƌĞĂƉƉůŝĞƐƚŽƚŚĞ^ŽŵĞƌƐĞƚĚĂƚĂ ?dŚĞ ? ?A?ŽĨ ‘ŽƚŚĞƌ ?ĂĐƚŝǀŝƚǇŚĂƐďĞĞŶ
removed from Curry. 
 
Table B11: Comparison of numbers of consultation: GP and Nurse consultation total (000s); excl. setting 
 “KƚŚĞƌ ? 
Method / 
Data 
CHE - 
existing 
Deloitte ONS-existing Curry 2015 Hobbs et al 
2016 
CHE 
Somerset 
data 
 Survey 
(3 months) 
Extrapolation Extrapolation CPRD 
Somerset 
CCG data 
2008/09 287,806 293,247 293,247 
 
244,567  
2009/10 294,335 303,763 297,352 
 
253,486  
2010/11 285,246 316,107 304,489 232,153 257,044  
2011/12 298,438 327,199 312,101 239,513 262,855  
2012/13 309,553 337,914 317,407 246,071 272,051 246,959 
2013/14 309,642 349,245 n/a 245,089 275,750 242,691 
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As can be seen there is a wide range in the estimates of volume of consultation rates in 2013/14, 
ranging from approximately 245 million consultations to 349 million consultations, with an average 
estimate of 284 million GP and Nurse Consultations.  The Deloitte estimate appears to be the main 
outlier with an estimate of over 60 million more consultations than the average.  That this is the 
highest estimate is primarily a function of an assumed ever increasing rate of consultations per 
person.  Not a single measure which uses contemporary data (CPRD, Somerset or survey-based) 
supports this assumption and as such, all other measures produce figures which are significantly 
below the much published Deloitte figure.  At the other extreme, the Somerset data not only 
indicate the lowest estimate of volume, but also a decrease since the previous year. 
 
Comparison of approaches in calculating growth rates 
Whilst the estimates of the volume of primary care activity are themselves interesting, the main 
objective of the report is to examine the extent to which they affect measures of productivity 
growth.  Estimates may show different amounts of consultations but similar patterns of changes 
over time.  It should be noted though, that estimates of greater volume will inflate the contribution 
that primary care growth makes to the overall NHS productivity measure. 
 
Table B12 shows the implied Laspeyres growth rates using cost data from Table 28 and a distribution 
of types of consultations based on Table 27 and applied to the correct levels of aggregation in the 
published data from the various sources.  'ƌŽǁƚŚƌĂƚĞƐĞǆĐůƵĚŝŶŐ ‘ŽƚŚĞƌ ?ĐŽŶƐƵůƚĂƚŝŽŶƐĂƌĞƌĞƉŽƌƚĞĚ
in Table B13. 
 
As can be seen there are still substantive differences across measures with the Deloitte and 
Somerset measures representing the two extremes.  There is a surprising difference between the 
two CPRD based measures. 
 
Table B12 PƐƚŝŵĂƚĞĚŐƌŽǁƚŚƌĂƚĞƐŝŶ'WĂĐƚŝǀŝƚǇ ?ŝŶĐůƵĚŝŶŐƐĞƚƚŝŶŐ “KƚŚĞƌ ? 
Method / Data CHE Deloitte ONS-existing Curry 
2015 
Hobbs et al 
2016 
CHE 
Somerset 
data 
 Survey 
(3 months) 
Extrapolation Extrapolation CPRD CPRD Somerset 
CCG data 
2007/08-2008/09   4.80%    
2008/09-2009/10  3.52% 1.40%  3.01%  
2009/10-2010/11 -3.09% 4.00% 2.40%  2.02%  
2010/11-2011/12 4.62% 3.45% 2.50% 5.24% 1.38%  
2011/12-2012/13 3.72% 3.22% 1.70% 3.77% 3.41%  
2012/13-2013/14 0.03% 3.30% n/a 1.57% 0.92% -1.66% 
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Table B13 PƐƚŝŵĂƚĞĚŐƌŽǁƚŚƌĂƚĞƐŝŶ'WĂĐƚŝǀŝƚǇ ?ĞǆĐůƵĚŝŶŐƐĞƚƚŝŶŐ “KƚŚĞƌ ? 
Method / Data CHE Deloitte ONS-existing Curry 
2015 
Hobbs et al 
2016 
CHE 
Somerset 
data 
 Survey 
(3 months) 
Extrapolation Extrapolation CPRD CPRD Somerset 
CCG data 
2008/09-2009/10 2.27% 3.52% 1.40%  3.01%  
2009/10-2010/11 -3.09% 4.00% 2.40%  2.02%  
2010/11-2011/12 4.62% 3.45% 2.50% 5.36% 1.38%  
2011/12-2012/13 3.72% 3.22% 1.70% 3.64% 3.41%  
2012/13-2013/14 0.03% 3.30%  0.94% 0.92% -1.73% 
 
B.6 Conclusions 
Our primary interest is in estimating the volume of primary care activity, but there are currently no 
comprehensive complete data sets of primary care activity in England.  In the absence of data, there 
are essentially three potential means of imperfectly addressing the issue. 
 
1. Use a large sample of data extracted from GP computer systems, such as QResearch, CPRD, 
THIN, ResearchOne or other data collection such as Somerset CCG.  These are unlikely to be 
representative of the population of practices or patients. 
 
2. Use data from national surveys which contain some (hopefully time-invariant) questions on 
primary care use.  These suffer the disadvantages that questions are rarely asked directly 
about the volume of consultations, that answers may be inaccurate, and that those 
surveyed may not be representative of the population. 
 
3. Extrapolate future predictions of use based on a historical time series, but as these are 
based on either survey or sample data.  We see this as the least satisfactory option. 
 
To some extent, we are fortunate that there exist a number of published analyses using different 
combinations of methods and sources.  Although the detail may be lacking in what is publically 
available, the data do permit simple comparisons of the main aspect of interest  W the measure of 
activity growth. 
 
The comparison of methods generally shows that, unsurprisingly, using different sources yields 
different estimates of primary care activity. It also highlights an anomaly in that what seems to be 
essentially the same method (extrapolation of linear trend) on the same data yields very different 
results (Deloitte versus ONS existing and Hobbs et al versus Curry).   
 
With no gold standard against which to compare measures, it is difficult to draw definitive 
conclusions from the analysis.  However, that is not to say that we regard all methods as being 
equally likely to produce reliable measures of activity. Our largely pragmatic conclusions are: 
 
x Measurement should be based on some actual measurement of contemporary data which 
pertains to measure activity in the period under analysis, i.e. extrapolation of historical time-
series data is not desirable. 
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x Measurement based on actual observed activity should be preferred to stated activity, i.e. 
we prefer sampled observational data to survey data.  This is conditional on the perceived 
quality/representativeness of the data which may in itself be difficult to measure, though 
there may be occasions when this is obvious (e.g. CPRD data). 
 
x Given the uncertainty, primary care should be subject to greater sensitivity analysis than is 
currently conducted.  A base case should be selected on the basis of perceived quality of 
available data  W this may not remain constant over time.  Alternative measures using other 
sample or survey data should be considered in the sensitivity analysis. 
 
x Survey data give every indication of improving in the near future with large scale surveys 
using questions which are more directly related to the measurement of activity.  With such 
measures it may be possible to assign confidence intervals to the measure and/or synthesise 
evidence.  When using survey data, population adjustment is necessary. 
 
'ŝǀĞŶƚŚĞƐĞƉƌĞĨĞƌĞŶĐĞƐ ?ƚŚĞƌĞŝƐŶŽĐůĞĂƌ ‘ďĞƐƚ ?ĞƐƚŝŵĂƚĞŽĨƉƌŝŵĂƌǇĐĂƌĞĂĐƚŝǀŝƚǇ ? Our proposed 
solution is, therefore, a pragmatic one as there is no standard best source and our ability to measure 
genuine activity may vary substantially year to year.  As a result, researchers should consider each 
year which are the best measures to use.  It may be advisable to continue to use the GP Patient 
Survey as long as it remains in this form as a means of producing a consistent measure over time, 
but there may be occasions when there are better data available and the base case measure may 
change over each paired year comparison.  
 
